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Introduction & Thesis Overview 1 
Introduction 
 
Due to its possibility of noninvasive, three-dimensional examination of biological 
events in living organisms and its capability to formulate diagnosis and follow 
treatments, magnetic resonance imaging (MRI) has been recognized as a powerful 
technique in medicine [1-4]. In order to increase the contrast of the MRI images, which is 
essential for a better and more precise detection, contrast agents (CAs) can be used [5,6]. 
The gadolinium chelates are the most common compounds used as CAs: they are 
characterized by a strong paramagnetism due to the seven unpaired electrons, thus giving 
a source of shortening of the longitudinal T1 and transverse T2 nuclear relaxation times. 
However, the recently acquired good control in the synthesis of superparamagnetic (SP) 
compounds [5-7] have given new perspectives to the use of low-toxicity novel and 
possibly multifunctional CAs. The ideal multifunctional SP-based compounds should be 
able to have applications not only in the diagnostics, e.g. MRI, but also in the treatment, 
e.g. drug delivery and hyperthermia. In this regard, superparamagnetic iron oxide 
nanoparticles (SPIONs), are the most promising candidate, not only for their efficacy in 
enhancing magnetic resonance image contrast but also for their high biocompatibility 
[8,9].  
The SPIONs are currently commercially produced. Endorem® (by Guerbet Group, 
Feridex in the USA) is one of the most known commercial MRI contrast agents and it is 
constituted by a magnetic core (diameter ~67nm) of mixed -Fe2O3 and Fe3O4 oxides 
coated with dextran, giving a nanoparticle which has an average ~150 nm hydrodynamic 
diameter. Despite the undoubtful efficacy of Endorem®, problems of reproducibility of 
the MR images are often encountered, possibly because the nanoparticles present high 
polydispersity and different batches of sample possess different mix of the two iron 
oxides. The limited reproducibility together with the necessity of obtaining systems with 
better controlled microscopic properties, have motivated many research groups to 
synthesize new monodispersed SPIONs families.   
The central idea of the research activity reported in the thesis has been the study of 
novel magnetic nanoparticles (MNP) for application as contrast agent (CA) in MRI and 
future other diagnostics and therapeutics, such as optical imaging, targeted drug delivery, 
and magnetic hyperthermia. A second part of research was related to fundamental aspects 
of magnetism, in which the spin dynamics and magnetic properties of molecular 
nanomagnets were studied. Concerning the second part of research we have just reported 
the related publications [10,11] in the Appendix B while in the main body of the thesis 
we will focus on the application part of the research, i.e. biomedical applications of 
MNPs. 
To test the efficiency of new samples in contrasting the MR images, we have 
investigated magnetic and relaxometric properties of two different types of novel 
superparamagnetics nanoparticles: 
 
1. Polymer-based nanostructured bio-ferrofluids. These materials, in brief bio-
ferrofluids, are candidates for the hyperthermia, optical imaging, and MRI. Bio-
ferrofluids are a series of novel maghemite/polymer composite ferrofluids with 
variable magnetic core size. Our investigations have shown that they have a good 
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efficiency as MRI CAs. These biocompatible ferrofluids, which contain anchoring 
groups for bio-functionalization, can incorporate fluorescent dyes and have shown 
low cellular toxicity in previous studies. Therefore, they can be proposed as 
possible platforms for multifunctional biomedical applications. The NMRD profiles 
showed that the efficiency parameter, i.e. the nuclear transverse relaxivity r2 , for 
particles with sizes greater than 10nm assumes values comparable with or better 
than the ones of commercial samples. The best results have been obtained in 
particles with the biggest magnetic core. The MRI in-vitro experiments, at =8.5 
MHz, using the gradient-echo and spin-echo sequences have confirmed the NMRD 
results, thus allowing us to suggest these superparamagnetic nanoparticles as novel 
multifunctional materials. 
 
2. Superparamagnetic colloidal nano-crystal clusters. These compounds are 
candidates for the targeted drug delivery and MRI. They are a novel class of 
superparamagnetic colloidal nano-crystal clusters (CNCs) coated with different bio-
compatible coatings such as polyethylene glycol fumarate (PEGF). We have 
investigated cell endocytosis, drug release, NMR relaxometry and in vitro MRI of 
CNCs with various biocompatible coatings. It is shown that the transverse relaxivity 
r2 for the PVA-coated, PEGF-coated, and crosslinked PEGF-coated CNCs is 
efficient enough to contrast suitably the magnetic resonance images. The same 
samples have shown a good ability also in controlled drug releasing (particularly 
the crosslinked PEGF-coated compound), thus finally allowing us to propose this 
class of compounds for future applications in theranostics, i.e., therapy and 
diagnostics with the same compound.    
 By means of the work done in this thesis, we were able to conclude that both classes of 
compounds investigated can be proposed as novel theranostic, i.e. therapy and 
diagnostics with the same compound, agents. 
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1.1 Nuclear Magnetic Resonance (NMR)  
 
Nuclear Magnetic Resonance (NMR) is a technique that uses a static magnetic field B0 
and a Radio Frequency (rf) pulsed field B1, which cause a specific kind of nuclei to 
absorb energy from the rf pulse and radiate this energy back out. The energy radiated 
back out is at a specific resonance frequency which depends on the strength of the 
magnetic field B0. The received signal depends also on  other experimental factors such 
as electronic noise, amplifier gain, receiver gain, etc. This allows the observation of 
specific quantum mechanical magnetic properties of an atomic nucleus. Many scientists 
exploit NMR phenomena to study molecules, liquids, crystals and non-crystalline 
materials. NMR with additional magnetic field gradients is also routinely used in 
advanced medical imaging, the so called Magnetic Resonance Imaging (MRI). 
Spin is an intrinsic property of some atomic nuclei. Stern-Gerlach experiment, in 
which a beam of silver atoms were passed through a magnetic field and split into two 
beams, was the first approach to the existence of the spin in 1922. The two beams 
represent two spin states, up   and down   of the silver nuclei. The nuclear "spin" 
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represents the total intrinsic angular momentum and is represented by the vectorial 
symbol I. According to the quantum mechanics laws, we can know simultaneously the 
length of I,     together with only one of its components, conventionally assumed as the z-
component Iz, that is: 
                                                           2 1I I I   h                                                1.1 
 
                                                                zI m h                                                         1.2 
 
where I is the spin quantum number, m=(-I, -I +1, . . . , I - 1, I) is the magnetic 
quantum number and h  is Planck’s constant divided by 2 . In the case of spin 1/2 
nuclei (I = 1/2), like the two most abundant silver isotopes or 1H, m can only be equal to -
1/2 or 1/2. A magnetic moment, µ, is associated to each nucleus with spin angular 
momentum, by the formula: 
 
                                                                   µ = γI                                                         1.3 
 
Using the Eq. 1.2 we will have: 
 
                                                           z zI m    h                                                  1.4 
 
where γ is the gyromagnetic ratio (magnetogyric ratio), an intrinsic property of each 
nucleus. At fixed abundance, nuclei with higher values of γ have higher sensitivity and, 
as a consequence, NMR spectra with better signal-to-noise (SNR) ratio. In fact, 1H is the 
most commonly used isotope in magnetic resonance because of his abundance and 
sensitivity. 
 
1.2 Magnetic Materials in a Static Magnetic Field 
 
For performing a NMR experiment, a sample is placed into a static magnetic field of 
magnitude B0. The energy of a magnetic moment µ immersed in B0 is given by: 
 
                                                               . 0μ BE                                                        1.5 
 
 The z axis is conventionally chosen along B0 so that: 
 
                                                                  B0 = B0 k                                                     1.6  
 
The energy of one isolated nuclear spin with magnetic moment µ, with substitution of 
Eqs. 1.6 and 1.4 in Eq. 1.5, can be written as: 
 
                                                         0 0z zE B I B                                                1.7 
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Therefore, using Eq. 1.2, the energy of the spin state Em with the specific quantum 
number m can be written as: 
 
                                                        0mE m B  h                                                        1.8 
 
As typical case of materials let us now switch to a system composed of a collection of 
identical I=1/2 nuclei; thus characterized by a total magnetic moment (i.e. nuclear 
magnetization) /M μii V . We can re-apply the Eqs. 1.5-1.7 also to M  as we did for 
the μ .  
As it is shown in Fig. 1.1, in zero field, the net magnetic moment of the system is zero, 
because the up   and down   states have the same energy and are equally populated. 
As sample feel an external magnetic field, a non-zero energy difference between the 
states (known as the Zeeman splitting) will appear, which by using Eq. 1.8 can be 
expressed as: 
 
                                                 0E E E B     h                                                 1.9 
 
According to the Boltzmann distribution, just a small excess of nuclei fall into the 
lower energy   state: 
exp
B
N E
N k T


    
                                                   1.10 
 
where kB is the Boltzmann’s constant, T is the absolute temperature and /N N   is 
the ratio between the populations of the states. 
 
 
 
 
 
FIG. 1.1 Splitting of nuclei spin states in an external magnetic field. 
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As an example, the fractional population difference at equilibrium at B0=1.5 Tesla and 
300 K is: 
                                                       65 10
N N
N N
  
 

                                              1.11 
 
If now a rf field B1 at frequency 0B  is applied, the NMR signal, after switching off 
B1, is produced by this very low number of excited nuclei. 
 
1.3 Magnetization and Radio Frequency Pulses 
 
From Planck’s law, E h  , and Eq. 1.9, the frequency 0  of an NMR transition in a 
magnetic field B0 is: 
                                                       00 2
BE
h
 
                                                     1.12 
or, given 0 / 2   , 
                                                           0 0B                                                            1.13 
 
where 0  or 0  is called Larmor frequency (rad/sec or Hz), B0 is the static field 
strength (Tesla) [1]. 
When rf pulses, producing an electromagnetic field, are transmitted in a plane 
perpendicular to B0, NMR transitions are induced [2]. It is conventional to represent the 
oscillatory rf field as a sum of two circularly polarized components, each of amplitude 
B1, counter-rotating in the xy-plane at angular velocity  . One of these components will 
rotate in the same sense of the nuclear spin precession: 
 
                                           t  = B cos t  - sin t1B i j                                            1.14 
 
This magnetic field is the responsible for the resonance phenomenon occurring when 
0  . The counter-rotating component can be ignored provided that 1 0B B= , which is 
invariably the case in NMR experiments. 
The time dependence of ( )M t is deduced from a formula expressing the Larmor precession 
typical of classical (quantum) magnetic moments:  
 
                                                   ( ) ( ) ( )M M Bd t t t
dt
                                               1.15 
 
which is the equation of motion of M in the laboratory reference frame and B is the 
sum of the static field B0 and the rotating rf field B1: 
 
                                                       ( ) ( )0 1B B Bt t                                                   1.16 
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Now it is worth to introduce a new reference frame, ( , , )x y z   , rotating with respect to 
the laboratory frame. In the rotating frame, z z   and the x y  -plane rotates around z at 
frequency  . The magnetization components in the rotating frame versus the laboratory 
frame, in complex notation, can be written as: 
 
                                                        i tx y xyM M e

                                                      1.17 
 
                                                          z zM M                                                           1.18 
 
where the magnetization vector is assumed to be: 
 
                                                      M i jxy x yM M                                                   1.19 
 
                                                     M i jx y x yM M                                                    1.20 
 
Eq. 1.14 can be written in complex notation as: 
 
                                                       1 1( )
i t
xyB t B e
                                                    1.21 
 
Applying the transformation Eq. 1.17 and choosing the x -direction along B1, it is 
easily seen that in the rotating frame, B1 is a static field lying in the x y  -plane. 
In the rotating frame, Eq. 1.15 becomes (see [3]): 
 
                                                 ( ) ( ) ( )M M Beff
d t t t
dt
                                             1.22 
 
where the effective field Beff is: 
                                                         ωB Beff                                                         1.23 
 
and: 
                                                            ω k                                                          1.24 
 
where k coincides with k . Eq. 1.22 shows that, considering the fact that the 
magnetization will precess about Beff, the equations of motion in the laboratory frame and 
in the rotating frame are formally the same.  
Using the Eq. 1.16, Beff can be written as: 
 
                                     0 1( )0 1
ωB B B k Beff B                                            1.25 
 
where Eqs 1.6 and 1.24 have been used. Under resonance conditions ( 0  ), holds: 
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                                            0 0 11B k B =Beff
 
 
                                                 1.26 
 
where Eq. 1.13 has been used. Note that, the longitudinal component of the effective 
field gets cancelled. 
According to Eq. 1.22 and last findings, when a rf pulse of length   is applied to the 
sample, M precesses about B1 (i.e., x ) with the frequency: 
 
                                                            1 1B                                                           1.27 
 
Therefore, at the end of the pulse, the magnetization will form the angle  , so called 
Flip Angle (FA), with the z-axis (see Fig. 1.2b): 
 
                                                            1                                                            1.28 
 
FA is one of the most important parameters characterizing a rf pulse in NMR. For 
instance, a 90 ( / 2)  -pulse flips the magnetization down to the y -axis and is some 
times called saturation pulse. 
Actually, in the laboratory frame, the magnetization will follow a time evolution 
shown in Fig. 1.2a which includes also the precession of the magnetization vector around 
B0.  
The behavior of the magnetization can be described by Bloch (Felix Bloch, 1946) 
equations [4], a set of coupled differential equations that describe the behavior of a 
nuclear spin in a static magnetic field, under the influence of rf pulses. Bloch modified 
Eq. 1.22 with the assumption that after switching off the rf pulses, the magnetization 
relaxes along z-axis and in the xy-plane at different rates, i.e. 1/T1 and 1/T2, respectively. 
T1 and T2 are called longitudinal (or spin-lattice) and transverse (or spin-spin) relaxation 
times, respectively. Adding the relaxation times to the Eq. 1.22 we will have: 
 
                           0
2 1
( )i j kM M B x y zeff
M M M Md
dt T T
                                      1.29 
 
where M0 is the thermal equilibrium value of Mz, that is, at equilibrium: 
                                                                  
                                                            0M kM                                                        1.30 
 
When the rf pulse is switched off (in other words at the end of the rf pulse), according 
to Eq. 1.26, 0Beff   and the Bloch equations can be written as: 
 
                                                          
2
x y x ydM M
dt T
                                                    1.31 
 
 
Chapter I: Introduction to NMR and MRI 10 
 
 
 
FIG. 1.2 Evolution of the magnetization vector in the presence of an on-resonance rf pulse. In the 
laboratory frame (a), the magnetization simultaneously precesses about B0 at 0  and about B1 at 1 . In 
the rotating frame (b), the effective longitudinal field is zero and only the precession about B1 is apparent. 
FA is the flip angle. 
 
 
 
 
 
 
 
                                               0
1
( )zz M MdM
dt T
                                                1.32 
 
where x yM    and zM   are the transverse and longitudinal magnetization components, 
respectively. Solutions for the Eqs 1.31 and 1.32 are: 
 
                                                  2/( ) (0) t Tx y x yM t M e

                                                 1.33 
 
                                       1 1/ /0( ) (0) 1t T t Tz zM t M e M e                                        1.34 
 
where t = 0 means immediately after the end of the pulse. If before applying the rf 
pulse the system is at thermal equilibrium, then we can write: 
 
                                                     0(0) sinx yM M                                                   1.35 
 
                                                      0(0) coszM M                                                  1.36 
 
By putting the magnetization vector back to the laboratory frame, one can see the 
combined effect of free precession and relaxation. To do that, we apply the 
transformation rules of Eqs. 1.17 and 1.18 to Eqs. 1.33 and 1.34, respectively, which 
gives: 
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                                             02/( ) (0) i tt Txy xyM t M e e
                                             1.37 
 
                                       1 1/ /0( ) (0) 1t T t Tz zM t M e M e                                        1.38 
 
where (0)xyM  is the transverse magnetization observed in the laboratory frame, 
immediately after the rf pulse. Eqs. 3.40 and 3.41 describe the magnetization precessing 
in the xy-plane of the laboratory frame at the Larmor frequency, while it is relaxing along 
the z-axis at a rate 1/T1 and relaxing in the xy-plane at a rate 1/T2. 
 
1.4 NMR Signal 
 
The signal of the NMR experiments is detected by a receiver coil. This signal, 
according to Faraday induction law and the principle of reciprocity, represents the 
electromotive force (emf), in volts, induced by the precessing magnetization and can be 
expressed by: [5] 
 
                             ( ) ( , ). ( )M r B r rM recsample
temf t d
t t
                                  1.39 
 
where M  is the magnetic flux in webers through the coil which is time dependent 
and ( )B rrec  is the reception magnetic field produced at location r by a hypothetical unit 
current flowing in the coil. The symmetry axis of the coil is perpendicular to the applied 
field, so that only the transverse magnetization which places in the xy-plane can induce 
some signal and be detected by the coil. Usually, the rf coil that transmits the B1 field, 
receives the induced signal as well. 
Assume that the equilibrium magnetization of a system is placed in the xy-plane by 
applying a 90○-pulse. According to Eqs. 1.35 and 1.37, the transverse magnetization 
component in the laboratory frame at time t, following the pulse, is: 
 
                                                  02/0( )
i tt T
xyM t M e e
                                              1.40 
 
where the pulse duration   is assumed to be negligible with respect to the Larmor 
precession time. This assumption allows to neglect the phase shift accumulated during   
between (0)x yM    and (0)xyM . If the receiver coil has a homogeneous reception field 
( )B rrec  over the sample, it can be shown that the signal takes the following expression: 
 
                                                   02/0( )
i tt TS t S e e                                                   1.41 
where S0 is the signal amplitude immediately following the pulse, a number which 
depends on the hardware configuration and is proportional to M0. The initial NMR signal 
is measured in the time domain as an oscillating, decaying emf induced by the 
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magnetization in free precession: it is therefore known as the Free Induction Decay (FID) 
signal. An example of FID is shown in Fig. 1.3. 
The FID signal resulting from a generic -pulse of a sample with the spectral density 
function ( )   takes the following form: 
 
                                       ( ) sin ( ) i tS t K e d                                                1.42 
 
where K accounts for the hardware configuration and ( ) ( )dM d    . The real 
part of the Fourier transform (FT) of the signal gives the absorption NMR spectrum. 
 
 
 
 
 
 
FIG. 1.3 Typical example of FID signal.  
 
 
 
 
 
1.5 Magnetic Resonance Imaging (MRI) 
 
The body is mainly composed of water molecules. Each water molecule has two 
hydrogen nuclei or protons. Actually, the MRI is mainly the 1H NMR applied to the body 
and its principles are the same as NMR. Although the research activity of the present 
thesis has not been concentrated on the MRI technique and the scanner has been used just 
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for performing the in-vitro images to find out the samples contrast efficiency, it would be 
worth to know the MRI hardware. So, in this section, first we will briefly introduce the 
MRI hardware and then some very important pulse sequences will be introduced. More 
details about a typical MRI system are given in the Appendix A.  
In a MRI scanner, a permanent magnet, an electromagnet or more often a 
superconducting magnet, produces the required static field B0 for the imaging procedure 
(normally B0=1.5 Tesla, but could reach 11 Tesla). The first coil historically used in an 
NMR experiment was the multi-turn solenoid coil. After that, the birdcage coil (Fig. 1.4) 
was introduced by Hays [6] and became the most routinely used volume coil in MRI, 
especially for imaging the head and brain. 
 
 
 
 
 
 
FIG. 1.4 Scheme of a Birdcage Coil with the magnetic fields directions. 
 
 
 
 
 
It is widely acceptable that the birdcage coil provides a better overall magnetic field 
homogeneity and improved SNR compared to older coil designs, such as the solenoid 
coils. Field homogeneity ensures that the atomic nuclei are excited by a uniform field, 
allowing a large field of view (FOV), while the high SNR allows obtaining high 
resolution images. Actually, the ability of birdcage coils to produce circularly polarized 
fields using quadrature excitation can increase the SNR by 41%, giving more 
resolution.[7] 
Sometimes the birdcage coil is shielded from other coils (e.g., gradient coils) inside 
the MRI set-up to minimize any interference. The birdcage coil was the basis for further 
improvements in coil design and assembly. New designs were developed and used, such 
as end-capped birdcage resonator and the double tuned quadrature birdcage coil. A 
birdcage coil or other types of rf coils can alternatively be used as a transmitter coil, 
receiver coil, or both receiver and transmitter. 
The transmitter coil creates the rf magnetic field B1 that excites the nuclei of the 
tissue. It is essential to have a uniform field B1 over the region of interest to provide a 
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spatially uniform excitation. If inhomogeneous magnetic field is created, some of the 
nuclei are either not excited or excited with different flip angles, leading to poor image 
contrast and SNR. The receiver coil detects the resonance signal resulting in an output 
voltage. 
According to the NMR principles discussed before, as the nuclei relax back to their 
original state, they emit some rf energy that has the same frequency as the applied rf 
signal, i.e. the NMR signal. With different tissues, the nuclei are present at different 
densities and relax at different frequencies and/or rates leading to different time-varying 
signal levels and consequently different tissue contrast in the image. Using three further 
coils to generate magnetic field gradients in the three perpendicular directions (x,y,z), the 
spatial location of different molecules is determined and the measured signal is 
transformed to an image via signal processing tools. 
An important issue to be considered for using an appropriate coil is the size of the coil. 
The body organ to be imaged should be comparable with the coil size. In such case, one 
achieves a good SNR which is due to the fact that the system is less sensitive to the 
external thermal noise and the receiver coil is close to the region of interest. This factor 
becomes more important at high magnetic fields. 
Surface rf coils are very popular because they serve as a receive-only coil, but their 
sensitivity drops off as the distance from the coil increases. They have a good SNR for 
tissues adjacent to the coil. The advantage of the surface coils is their ability to produce a 
strong and localized rf field that can provide a high SNR compared to other coils, 
especially in the imaging of relatively small volumes. 
Scan room is surrounded by an rf shield. The shield prevents the various external rf 
signals (e.g. television and radio signals) from being detected by the imager. Some scan 
rooms are also surrounded by a magnetic shield, which prevents the magnetic field from 
extending too far into the hospital. In newer, powerful magnets, the magnet shield is an 
integral part of the assembly. The patient is positioned within the magnet by a computer 
controlled patient table. The table has a positioning accuracy of 1 mm. 
The heart of the MRI system is the computer. It controls all the components of the 
scanner. The computer also controls the rf components: rf source and pulse programmer. 
The source produces a sinusoidal wave at predetermined frequency. The pulse 
programmer converts the rf pulses into desired pulse shapes as dictated by the operator. 
The rf amplifier increases the pulse power from milliwatts to kilowatts. The computer 
also controls the gradient pulse programmer, which sets the shape and amplitude of each 
of the magnetic field gradients which will be introduced later. The gradient amplifier 
increases the power of the gradient pulses to a level sufficient to operate the gradient 
coils. 
 
1.5.1 Pulse Sequences 
 
One of the confusing aspects of MRI is the variety of pulse sequences available from 
different equipment manufacturers. A pulse sequence is the measurement technique by 
which a MR image is obtained. It contains the hardware instructions (rf pulses, gradient 
pulses and timings) necessary to acquire the data in the desired manner. 
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As implemented by most manufacturers, the pulse sequence actually executed during 
the measurement is defined from parameters directly selected by the operator (e.g. TR 
and FOV) and variables defined in template files (e.g. relationships between rf pulses and 
slice selection gradients). This allows the operator to create a large number of pulse 
sequence combinations using a limited number of template files. It also enables the 
manufacturer to limit parameter combinations to those suitable for execution. 
Sometimes, similar sequences may be known by a variety of names by the same 
manufacturer.[8] As a result, comparison of techniques and protocols between 
manufacturers is often difficult due to differences in sequence implementation. To have 
such a comparison, knowledge of confidential, proprietary information might be needed. 
A pulse sequence sets the specific number, strength, and timing of the rf and gradient 
pulses. The signal intensity and consequently the image contrast of the MR image can be 
manipulated by changing the pulse sequence parameters. Generally, the signal intensity 
might be determined by four basic parameters: 1) proton or spin density, 2) T1 relaxation 
time, 3) T2 relaxation time, and 4) diffusion effects. Proton density is the concentration of 
protons (hydrogen atom nuclei) in the tissue belonging to water and macromolecules 
(proteins, fat, etc). The T1 and T2 relaxation times define the signal behavior after 
excitation as well as the way the protons revert back to their equilibrium after the initial rf 
pulse excitation. 
In a pulse sequence, the most important parameters which affect the signal intensity 
are the repetition time (TR), the echo time (TE), and the tissue nuclear spin, e.g. proton, 
density  . The TR is the time between consecutive identical sequences. The TE is the 
time between the initial rf pulse and the time at which the signal is received. Therefore, 
the signal intensity SI (and consequently the image contrast in the MRI) can be written 
as: 
 
                                       1 2/ /( , ) (1 )TR T TE TSI TR TE e e                                              1.43 
 
where   is the density of nuclear spins. 
As one can see in Eq. 1.43, using the appropriate pulse sequences, it is possible to 
weight the image on T1, T2, or the nuclear spin (e.g. proton) density, so called T1-
weighted, T2-weighted and proton density (PD)-weighted sequences, respectively. In 
order to weight on a desired parameter and consequently eliminate the others, one has to 
rely on the relaxation times of the tissue. As given in Table 1.1, the T1-weighted sequence 
uses a short TR and short TE (TR < 1000 ms, TE < 30 ms). The T2-weighted sequence 
uses a long TR and relatively long TE (TR > 2000 ms, TE > 80 ms) while to have a PD-
weighted image one has to use  short TE and long TR values. More recently, the FLAIR 
(Fluid Attenuated Inversion Recovery) sequence has, in some cases, replaced the PD 
image. FLAIR images are T2-weighted with the cerebrospinal fluid (CSF) signal 
suppressed [9]. Fig. 1.5 illustrates the possibilities of generating different contrast from 
two types of tissues with different relaxation characteristics. The examples of different 
generated contrasts are given in Fig. 1.6.  
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TABLE 1.1 TR and TE dependence of image weighting. 
TE TR Image weighting 
short long proton 
short short T1 
long long T2 (T2*) 
 
 
 
 
 
 
 
                                                                               
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIG. 1.5. Longitudinal magnetization recovery and transverse magnetization decay of two different 
tissues. Dashed lines show how appropriate values of TR (in the longitudinal magnetization recovery 
curves) and TE (in the transverse magnetization decay curves) gives the a) PD-weighted, b) T2-weighted, 
and c) T1-weighted images.   
(a) 
(b) 
(c) 
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FIG. 1.6 a) T1-weighted, b) T2-weighted, and c) PD-weighted images of the brain. 
 
 
 
 
 
There are two most commonly used pulse sequences in MR imaging: 1) Spin Echo 
(SE) sequence, and 2) Gradient Echo (GRE) sequence. 
 The concept of the SE production was developed by Hahn in 1950 and that’s why the   
Spin echoes are sometimes referred to as Hahn spin echoes. The Hahn Spin Echo 
sequence consists of a 90○ flip pulse followed by a 180○ flip pulse (after an interpulse 
delay time  ). A “spin echo” occurs at echo time TE ( 2 ) following the initial 90○ flip. 
Fig. 1.7 shows how the magnetization flips, dephases in the x-y plane, and gets in phase 
to produce the echo. 
 
 
 
 
 
 
FIG. 1.7 Scheme of the SE sequence. 
The Hahn spin echo is used for the measurement of T2 values.  It is possible to 
measure T2 since the spin echo technique compensates for the local inhomogeneities of 
(a) (b) (c) 
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the static magnetic field.  In order to measure T2, the sequence has to be repeated with 
several different values of the interpulse delay   and it is necessary to wait 
approximately five times T1 for complete recovery between repeated sequences. 
Carr-Purcell-Meiboom-Gill (CPMG) spin echo technique is a modified spin echo 
technique. The CPMG technique uses a 90○ rf pulse followed by a train of equally spaced 
180○ rf pulses along the Y axis of the rotating frame. Each echo signal is positive in the 
CPMG technique [10]. It should be mentioned that the signal envelope following the 90○ 
rf pulse follows the decay time so called T2* (see Fig. 1.8), while the signal envelope 
connecting the magnitude of succeeding echoes has a time costant T2. The CPMG pulse 
sequence is illustrated in Fig. 1.8. 
In a SE sequence a multi-slice loop structure is used to acquire signals from multiple 
slices within one TR time period. 
On the other hand, the GRE sequences do not use a 180° pulse to refocus the protons. 
Rather, the echo signal is generated only through a refocusing external field gradient. The 
application of a first refocusing imaging gradient induces proton dephasing. Application 
of a second gradient pulse of double duration and same magnitude but of opposite 
polarity reverses this dephasing and produces an echo known as gradient echo. Fig. 1.9 is 
showing the timing diagram of the GRE pulse sequence. 
In all of the GRE sequences the excitation angles (FA) are usually less than 90°. 
The absence of the 180° rf pulse in gradient echo sequences has several important 
consequences. The sequence kernel time may be shorter than that for an analogous SE 
sequence enabling more slices to be acquired for the same TR if a multi-slice loop is used 
[11]. More information or details can be revealed once more slices are used. Moreover, it 
implies that less total rf power is applied to the patient, so that the total rf energy release 
is lower. 
Additional contrast mechanisms are also possible. In fact the static sources for proton 
dephasing, which are magnetic field inhomogeneity and magnetic susceptibility 
differences, contribute to the signal decay. As such, the TE determines the amount of *2T -
weighting in a gradient echo image rather than only T2-weighting, as in a spin echo 
image. 
The overall signal level in gradient echo images is expected to be less than that in spin 
echo images, with comparable acquisition parameters. The image quality of GRE 
sequences is also more sensitive to metal implants and to the region of anatomy under 
investigation. In addition, fat, protein and water protons within a voxel also contribute 
with different amounts of signal depending upon the chosen echo time, due to their 
different frequencies and hence different phases at echo time. 
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FIG. 1.8 CPMG pulse sequence timing diagram. 
 
 
 
 
 
FIG. 1.9 gradient-echo pulse sequence timing diagram. The TE time is measured from the middle of the 
excitation pulse to the center of the echo.  
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2.1 Image Contrast 
 
The tissue contrast to noise ratio (CNR) appearing in MR image is the basis for a 
medical diagnosis. The CNR can be altered by the choice of specific pulse sequences (as 
discussed in chapter I, mentioned here after briefly) and the associated timing parameters. 
It is generally defined as: 
 
                                                     1 2SI SICNR
noise
                                                      2.1 
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SI1 and SI2 represent the signal intensities of two adjacent regions on an MR image. 
The magnitude of the detected signal depends upon the spin density (number of protons 
available), T1 and T2 characteristics of tissues, chemical shift, temperature, and flow 
phenomena. Among these parameters, the relaxation characteristics are mostly 
influencing the signal intensity. Therefore the conventional tissue contrast of an MR 
image, as explained in the first chapter, is usually proton-density- T1- or T2- weighted 
(see Eq. 1.43). A long TR (TR > 5 T1) allows enough time for a complete T1 relaxation 
and the longer the time interval TE the greater the extent of T2 relaxation. Spin echo 
images acquired with short TR (TR ~ T1) and a short TE (TE < T2) are T1-weighted. With 
shorter TR values, tissues such as fat which have short T1 values appear brighter, whereas 
tissues such as tumors and edema, that have longer T1 values and therefore take more 
time to relax towards equilibrium, appear darker. The short TE value diminishes the 
importance of tissue T2 differences. On the other hand, images acquired with long TR and 
long TE (TE ~ T2) are T2-weighted. Therefore, tissues with long T2, such as tumors, 
edema, and cysts appear bright whereas tissues that have short T2, such as muscle and 
liver, appear darker.  
In summary, the MR image contrast is a function of several parameters and the image 
contrast between tissues with different physicochemical properties is determined by 
different image signal intensities that each tissue produces when the operator chooses 
specific values of TR and TE.  
Despite the relatively high number of degrees of freedom for obtaining good MR 
images of the soft tissues of living beings, in some cases it is not possible to have enough 
image contrast to show the anatomy or pathology of interest. In such cases, one has to use 
a contrast agent (CA). The CAs should fulfill several requirements for clinical 
applications: adequate relaxivity and susceptibility effects, tolerance, safety, low toxicity, 
stability, optimal bio-distribution, easy elimination and good metabolism. In the 
following paragraphs we'll introduce briefly these systems, starting from their main 
physical properties.  
 
2.2 Magnetic Materials 
    
Magnetism is one of the basic properties of materials. When a material is placed in a 
magnetic field H, it acquires a dipole moment. The magnitude of this dipole moment 
depends upon the nature of the material, the applied magnetic field strength, and is 
proportional to its volume. Therefore, we define the total dipole moment per unit volume 
induced in the material as magnetization M, which is the sum of all the atomic/nuclear 
magnetic moments of the material. The response of the material to the applied magnetic 
field can be expressed, for 0,H   as: 
 
                                                            M H                                                           2.2 
 
where   is defined as the magnetic susceptibility, the most important magnetic 
material property. In paramagnetic substances it depends on the temperature according to 
Curie-Weiss expression: 
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                                                          C
T
                                                              2.3 
 
where C and θ are both characteristic constants of each material. As the applied field 
strength is increased for any particular material, the magnetization reaches a constant 
value, defined as saturation magnetization, Ms. 
The magnetic properties of an ion or atom are determined by the orbital angular 
momentum L  and by the spin angular momentum S, determined by the orientation and 
number of its electron spins. For magnetic metal oxides (transition metal oxides in 
particular), the spin of an ion is characterized by one total spin (atomic spin). The atomic 
spins of neighboring ions may be strongly correlated with each other to form a spin sub-
lattice. Depending on the magnitude of the spin, the orientation and the number of spin 
sub-lattices, the material possesses a characteristic internal magnetic field, as well as 
characteristic responses to an applied magnetic field. Regarding the various kinds of 
responses of materials to a magnetic field, we introduce six basic categories: 1) 
ferromagnetic, 2) antiferromagnetic, 3) ferrimagnetic, 4) paramagnetic 5) diamagnetic 
and 6) superparamagnetic, materials. 
The atomic spin arrangements of various types of magnetic materials are 
schematically represented in Fig. 2.1. In ferromagnetic materials, the atoms with 
permanent dipole moments interact one each other, to produce a parallel alignment of 
spins in the crystal lattice below a critical transition temperature Tc. This generates a 
large magnetic susceptibility, and therefore strong response to the applied magnetic field. 
On the contrary, in antiferromagnetic materials, the dipole moments interact one each 
other showing an anti-parallel alignment in the crystal lattice. This spontaneous anti-
parallel coupling of atomic magnets is disrupted by heating and disappears entirely above 
a certain ordering transition temperature, called the Neel temperature, characteristic of 
each antiferromagnetic material. Above the Neel temperature the material is typically 
paramagnetic, i.e. the spins fluctuate almost independently with a correlation time τ of 
the order of 10-14-10-15s. Similarly to the antiferromagnetic alignment, ferrimagnetic 
materials have an anti-parallel spins alignment in the crystal lattice. However, the 
magnitudes of the oppositely aligned dipole moments are not equal, resulting in a net 
magnetic moment when placed in a magnetic field. Ferrimagnetic materials therefore 
have generally a smaller magnetic susceptibility than ferromagnetic materials. In the case 
of paramagnetic materials, the dipoles in the crystal lattice are randomly oriented and do 
not interact with each other. When a paramagnetic material is placed in a magnetic field, 
the magnetic moment of the material increases slowly initially in a linear M vs. H way, 
following then the Langevin function until saturation magnetization is reached. The 
phenomenon of the diamagnetism is instead characterized by the opposition of the 
magnetic moments inside the material, to the external magnetic field. 
In addition to the five categories of magnetic materials we have presented, there is a 
special magnetic phenomenon which shares properties of both paramagnetic and 
ferromagnetic materials, the so called superparamagnetism. Frenkel and Dorfman first 
predicted in 1930 that a particle of ferrimagnetic (or ferromagnetic) material could 
consist of a single magnetic domain below a certain critical size. It has been defined that 
a single domain particle will have a uniform magnetization at any field strength. In 1949, 
Nèel pointed out that if a single domain particle was small enough, the thermal 
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fluctuations could cause changes of direction in opposite senses of its magnetization 
similar to that of Brownian rotation. 
Bean and Livingston, in 1959, observed that the magnetization behavior of single 
domain particles (isotropic) in thermodynamic equilibrium at all fields is identical to that 
of atomic paramagnetism but that they have an extremely large moment. This large 
magnetic moment does not result from the individual atoms, but rather it comes from 
hundreds/thousands (depending upon the particle size) of atoms in the particle which are 
ferromagnetically coupled by exchange forces. When a magnetic field is applied to a 
suspension of small ferromagnetic particles, they are partially aligned by the field and 
partially disordered by the thermal motion, thereby exhibiting over-all paramagnetism. 
In the following, we present some fundamental aspects of superparamagnetism. 
 
 
 
 
 
FIG. 2.1 Spins arrangements in various magnetic materials. 
 
 
 
 
2.2.1 Nanoparticles and Single Domain Particles 
 
When the volume of a particle is reduced below a certain value, called critical domain 
size Dc, the proximity of many domain walls in a small volume is not energetically 
favored, so that a single-domain [1] configuration is adopted. For spherical crystals, 
Kittel proposed the following expression for the critical diameter [2]: 
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                                                  2036 /c sD E M                                                         2.4 
 
where Eσ = 2 (A.K)1/2 is the surface energy of a Bloch wall in an infinite material with 
low anisotropy, K is the anisotropy constant, A is the exchange energy, 0  is the vacuum 
permeability, and Ms is the saturation magnetization.  
In Table 2.1 we present the critical diameters of some common magnetic spherical 
nanoparticles together with the anisotropy, saturation magnetization, and exchange 
energy values used for their evaluation [3]. 
 
 
 
 
 
TABLE 2.1 Examples of critical diameters for some common magnetic spherical nanoparticles together 
with the anisotropy, saturation magnetization, and anisotropy constants used for their evaluation [3]. 
 
Magnetic Material A (J.m-1) Ms (J.m
-1) 
(bulk) K (J.m
-3) Dc (nm) 
Fe (bcc) 0.5 0.5 59 0.16 
Fe3O4 0.625 0.5 62 0.18 
 -Fe2O3 1 0.5 92 0.15 
 
 
 
 
 
The values of critical diameter in the table are indicative, and can change with the 
quality of the nanomaterials. Magnetite and maghemite present quite similarly magnetic 
properties (saturation magnetization and critical diameter of the same order). On the 
contrary, cobalt ferrite has a high anisotropy inducing a relatively low critical diameter. 
In case of pure iron the high saturation magnetization induces a critical diameter ten 
times lower than magnetite. Finally, as shown in Fig. 2.4, between single domain and 
multidomain size range there is a broad region called pseudo single-domain. 
When a magnetic field is applied, for non-interacting nanoparticles, the magnetization 
reversal for single domain nanoparticles is realized by coherent rotation, meaning that all 
spins of the ions in nanoparticles are parallel to each other. One of the most recognized 
models describing the coherent rotation of magnetization for an assembly of non-
interacting single domain magnetic nanoparticles with uniaxial anisotropy is the Stoner-
Wohlfarth theory [4]. 
This model represents single particles through classical giant spin with a certain 
anisotropy. According to this model the hysteresis cycle of a single particle critically 
depends on the angle between the applied field and the anisotropy axis (or easy axis), 
which is defined as the energetically favorable direction of the spontaneous 
magnetization. Two extreme cases are possible at much lower than the anisotropy energy 
Ea (see below for the definition): 
Chapter II: MRI Contrast Agents 26 
1. If the particle anisotropy axis is perpendicular to the direction of the applied 
field the hysteresis branches are superimposed, and there is no coercive field 
Hc and remanence magnetization Mr. 
2. If the particle axis is instead parallel to the applied field, the hysteresis cycle is 
open and the coercive field can be obtained by: 
 
                                                    Hc = 2K / μ0 Ms                                                         2.5 
 
At intermediate angles one observes hysteresis cycles with coercive field and 
remanence that span between these two extreme positions. 
For an assembly of randomly oriented non interacting particles, the curve is expected 
to behave like Fig. 2.2, the coercive field is ≈ 0.5 Hc, while the remanent magnetization is 
0.5 Ms. 
 
 
 
 
FIG. 2.2 Theoretical hysteresis curve in Stoner-Wohlfarth model for a randomly oriented assembly of 
nanoparticles. 
 
 
 
 
2.2.2 Magnetic Anisotropy of Nanoparticles 
 
The magnetic properties of the nanoparticles are generally anisotropic. There are some 
low energy directions in the crystal, called easy directions, which are separated by an 
anisotropy energy barrier. Several different sources can give rise to the total anisotropy of 
the magnetization: 
i) Magnetocrystalline Anisotropy. This property is intrinsic to the material and it is 
related to the crystal symmetry and to the arrangement of atoms in the crystal lattice. The 
origin of this contribution lies in the spin-orbit coupling. In fact, the orbital wave function 
will reflect the symmetry of the lattice and the spins are made aware of this anisotropy 
via the spin-orbit coupling. 
ii) Shape Anisotropy. The source of this kind of anisotropy is the presence of free 
magnetic poles on the surface of a magnetized body. These poles create a magnetic field 
inside the system, called demagnetizing field. Variation from spherical form can induce 
competing shape anisotropy with respect to the magnetocrystalline contribution. 
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iii) Surface Anisotropy. When the surface atoms are present in a number comparable 
to that of atoms within the particle, another form of anisotropy is observable. This kind of 
anisotropy is very sensitive to the chemical environment of surface spins and may be 
different depending also on the chemical species bounded to the surface. The magnitude 
of this contribution increases on decreasing the size of the particle due to the increasing 
of surface to volume ratio. Néel has shown that the surface contribution becomes relevant 
only for particles smaller than 10nm [5]. 
iv) Stress Anisotropy. It is well known that when a specimen is magnetized in a given 
direction, there is a change of length in that direction. This phenomenon was first 
observed by Joule in 1842 and is called magnetostriction. Its existence indicates that there 
is an interaction between magnetization and strain, which is again due to spin-orbit 
coupling. Since the strain is related to any stress that may be acting on the considered 
system, this implies that the anisotropy energy depends on the stress state of the system. 
v) Exchange and Dipolar Anisotropies between Particles. Two particles, close enough 
to each other, will have a magnetic interaction. This interaction, which can be either due 
to magnetic dipole interaction or to exchange interaction, leads to an additional 
anisotropy energy. In this case the easy direction is determined by the relative orientation 
of the two interacting magnetic moments.  
The observed anisotropy energy depends on the relative magnitude of each 
contribution, which depends on the structure of the material, its shape and size [6]. 
 
2.2.3 Superparamagnetism 
 
 Energy Barrier and Blocking Temperature. In magnetic materials, the anisotropy can 
often be modeled as uniaxial in character and represented, in its simplest form, as: 
 
                                                    2( ) sinaE K V                                                       2.6 
 
where V is the volume of the particle and   is the angle between the magnetization 
direction and the easy axis, and K is the anisotropy constant. 
From this equation comes out that there are two energy minima corresponding to 0   
and    (Fig. 2.3). The energy barrier Ea=KV is defined as the energy required to move 
from one stable state to another. 
At a temperature T the magnetic state of the particle will be determined by the 
competition between Ea and the thermal energy kBT, where kB is the Boltzmann constant. 
At a given temperature T for which the thermal energy is much lower than the energy 
barrier (kBT < Ea), the probability that the magnetization forms an angle θ with the easy 
axis has a finite value only in correspondence of the two minima. Thus the magnetization 
will be blocked in one of the two easy directions. 
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FIG. 2.3 Anisotropy energy profile as a function of the angle between the magnetic moment and the 
easy axis for a single domain NP with pure uniaxial symmetry. 
 
 
 
 
On increasing temperature the allowed θ values will have a broader distribution 
around the two minima and the magnetization can begin to fluctuate around the easy 
directions (vibrations in the potential well). The vibration amplitude will increase up to a 
temperature at which thermal energy equals the energy barrier. This temperature is called 
blocking temperature, TB. Above TB thermal excitations will make the magnetic moment 
to freely rotate and therefore the net magnetization will average to zero in the absence of 
an external field. In this condition the assembly of particles behaves like a paramagnetic 
system, while individual atomic moments maintain their ordered state relative to each 
other. The blocking temperature (TB) is defined as the temperature at which the relaxation 
time is equal to the measuring time M , and is given by: 
 
                                                     
0ln /
B
B M
K VT
k                                                         2.7 
 
The Eq. 2.7 shows that the blocking temperature TB depends on the measuring time 
window, M , of each experimental technique. For example, a typical dc magnetization 
measurement spans an experimental time M  of ~102 s while M = 10-8 s for 57Fe 
Moessbauer spectroscopy and is between 0.16 and 10-4 s at frequencies between 1 and 
1000 kHz for ac susceptibility. 
Blocking temperature of nanomaterials depends on the energy barrier and then on the 
anisotropy constant and on the dimension of particles. At a given temperature, below a 
critical dimension ds, the nanoparticles will be superparamagnetic (Fig. 2.4). This value 
depends strongly on the anisotropy of the system. 
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FIG. 2.4 Coercivity at room temperature as a function of the size for nanoparticles; SPM: 
superparamagnetic, SD: single domain, MD: multidomain and PSD: pseudo-single domain. 
 
 
 
 
 
 
A superparamagnetic material is blocked (no remanence or coercivity) at room 
temperature. For the non interacting SPM particles, temperature variation in coercivity 
HC is expressed as [7]: 
 
                                               1/20 (1 / )C C BH H T T                                                2.8 
 
where HC0 is the value of HC when T → 0. Thus, the measured HC as a function of T1/2 
would be linear for noninteracting particle systems. 
At low temperatures the HC increases with the particle size d according to the law [7]: 
 
                                             3/2( ) 0.5 [1 / ]C k SH d H d d                                          2.9 
 
Where Hk=2K / μ0 Ms is the anisotropy field defined for uniaxial magnet. 
This model, however, makes the assumption that the nanoparticles are non-interacting, 
which is not always the case for the most of real systems. Indeed, magnetic interactions 
can have a strong influence on the reversal dynamics of the magnetic moment [8]. 
 
Superparamagnetic Relaxation. The reversal mechanism of the magnetization is 
characterized by the probability of switching the particle's magnetic moment μ among 
different spatial orientations or, in terms of the Néel model [9], by the relaxation time τ. 
Being a thermally activated process, the relaxation time of μ is described by the 
Arrhenius law: 
 
                                                             /0 a B
E k Te                                                         2.10 
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Where 0  is the pre-exponential factor referred to as "attempt time", and commonly is 
of the order of 10-9-10-12 s. 
Superparamagnetic particles align with the applied magnetic field by one of the two 
following mechanisms: (i) Néel rotation (ii) Brownian rotation. The Néel rotation occurs 
when particles are either in a fluid or in a solid matrix and results from the rotation of the 
magnetic moment of a stationary particle by overcoming the energy barrier. 
Brownian rotation only occurs when particles are in a fluid and results from the 
physical rotation of a particle towards the direction of the applied magnetic field (Fig. 
2.5) [10].  
Each of these processes is characterized by a relaxation time: τB for the Brownian 
process depends on the hydrodynamic properties of the fluid while τN for the Néel 
process is determined by the magnetic anisotropy energy of the superparamagnetic 
particles relative to the thermal energy. 
The relaxation times τB and τN depend differently on particle size. In the case of Néel 
relaxation the characteristic relaxation time of a nanoparticle system depends on the ratio 
of the anisotropy energy KV to the thermal energy kBT as described in Eq. 2.10. 
As concerns the Brownian relaxation mechanism, if a suspension of magnetic particles 
with viscosity η is considered, the characteristic relaxation time is given by: 
 
                                                         3 HB
B
V
k T
                                                            2.11 
 
where VH is the hydrodynamic radius. Debye first derived this equation [11] for 
rotational polarization of molecules.  
 
 
 
 
 
 
 
FIG. 2.5 Illustration of the two mechanisms of the magnetic relaxation in a magnetic fluid [12]. 
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In the general case, the faster relaxation mechanism is the dominant one and the 
effective relaxation time τeff is given by: 
 
                                                       1 1 1
eff N B                                                          2.12 
 
Interacting Superparamagnetic Systems. In all fine-particle systems, different kinds of 
magnetic interparticle interactions may exist and the interaction strength varies with the 
volume concentration. The different types of magnetic interactions, which must be 
considered, are: 
 dipole-dipole interaction: interparticle interactions may arise from dipole-
dipole interactions between nanoparticles. When a capping surfactant such as 
oleic acid is used, the increased spacing between particles results in negligible 
exchange interactions (see below) and the primary interaction is considered 
from the dipole-dipole coupling [13]. 
 Exchange interaction: The exchange interaction is actually an effect that arises 
from the interplay of electromagnetism with quantum mechanics. This 
interaction lies at the heart of the phenomenon of long-range magnetic order. 
When the electrons on neighbouring magnetic atoms undergo exchange 
interaction, this is known as direct exchange. Hence direct exchange 
interaction plays a big role in nanoparticle assemblies where the surfaces of the 
particles are in close contact. 
 Superexchange interactions: When the matrix is insulating, superexchange 
interaction can exist depending on the structure and the nature of the matrix 
and the bonding at the particle matrix interface. Exchange interactions are 
short ranged in insulating magnetic materials, but if the bonding is favorable, 
superexchange interactions may extend over large distances. 
 RKKY interaction: The RKKY (Rudermann-Kittel-Kasuya- and Yosida) is an 
indirect exchange that couples moments over relatively large distances. It is the 
dominant exchange interaction in metals where there is little or no direct 
overlap between neighboring magnetic electrons [14]. 
Different models have been developed over the past years for describing the effect of 
interparticle interactions, and the most used are the Shtrikman-Wohlfarth (SW) model, 
developed in 1981 [15], the Dormann-Bessais-Fiorani (DBF) model (1998) [16], and the 
Mørup-Tronc model (1994) [17]. Both the SW and DBF models show that increase in 
interparticle interactions will lead to an increase in the energy barrier Ea: 
 
                                                2( ) sina iE KV B                                                  2.13 
 
where Bi is the energy term from interaction. 
On the contrary the MT model indicates that increased interparticle interactions should 
decrease the energy barrier. On increasing the interaction strength a transition from a 
superparamagnetic state to a disordered collective state can be observed [18]. This state is 
called a superspin glass state by analogy with the disordered and frustrated magnetic state 
observed at low temperatures in spin glass materials [19]. 
Chapter II: MRI Contrast Agents 32 
Superspin glasses differ from canonical atomic spin glasses in several aspects. First, 
the interacting magnetic moments have very different amplitudes (102–104μB for strongly 
coupled spins in a single-domain magnetic nanoparticle compared to a few μB for an 
atomic spin) and the nature and range of their interactions are different (anisotropic and 
long range dipole/dipole interactions for magnetic nanoparticles vs shorter ranged 
exchange or longer range RKKY interactions for atomic spins). Additionally the 
characteristic time of the spin flip mechanism is very short (~10-12s) and nearly 
temperature independent in atomic spin glasses while it is much longer in superspin 
glasses, thermally activated and thus exponentially dependent on the ratio of the magnetic 
anisotropy energy Ea to the thermal energy kBT. 
Depending on the strength of the interaction one can use different magnetic models to 
describe the relaxation time of the ensemble. In case of interactions the Vogel-Fulcher 
model introduces in the Néel law an “ordering temperature”, T0: 
 
                                                       0/ ( )0 a B
E k T Te                                                     2.14 
 
For stronger interactions (closer distances) and if magnetic frustration and spatial 
randomness is present one can encounter a phase transition into a so-called superspin 
glass phase below a critical temperature, Tg. and   can be described by a power law: 
 
                                                       0
zv
g
g
T
T T
       
                                                 2.15 
 
where the critical exponent zν is related to the correlation length [20]. 
 
2.3 MRI Contrast Agents 
2.3.1 Introduction 
 
Most of the CAs are generally based on paramagnetic or superparamagnetic 
substances. The CAs used in MRI are selected to induce a shortening of the spin-lattice 
T1 and/or spin-spin T2 relaxation times of the hydrogen nuclei within the tissues/regions 
where they are delivered thus allowing a much better image contrast. Most commonly a 
paramagnetic CA, usually a gadolinium-based compound, is used [21,22]. Gadolinium-
enhanced tissues and fluids appear extremely bright, and for this reason paramagnetic 
CAs are called positive CA.  
More recently superparamagnetic (SP) CAs, based on iron oxide magnetic 
nanoparticles [23,24], have become commercially available. The regions where such 
agents are delivered appear very dark and therefore they are called negative CA. The big 
advantage of this type of CA is their sensitivity that is expected to reach single cell level 
[25]. 
As mentioned, CAs are used to provide the information at the cellular and molecular 
level. Increasing sensitivity and specificity proves to be the challenge for molecular and 
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cellular MRI. The detection of molecular or cellular events needs to exhibit specificity for 
the particular biological event. Specificity is therefore mainly reflected in the high ability 
of discriminating a particular molecule or cell from noise and other molecules. To 
achieve this high specificity, an antibody system targeting a particular antigen, for 
instance, will selectively bind the molecule/cell of interest [26,27]. By combining this 
antibody with a magnetic CA, it will be possible to provide a selective detection of the 
molecule or cell of interest with MRI. 
The properties of the MR CA will determine its binding characteristics to the molecule 
of interest, its tissue penetration and circulation, and potentially its cellular uptake [28]. 
Modifying MR CA into multifunctional entities (e.g., optical and MR imaging 
simultaneously [29]) enhances their attractiveness. 
Based on the functionalization of MR CAs, significant advances have been achieved 
in both cellular and molecular MR imaging. Notably, MR CAs can be shuttled into 
different types of cells in vitro or in vivo to track these by MRI [30], or they can be 
engineered to be attached to the particular molecules on tissues [31]. By engineering the 
CAs to only produce a signal change when bound to a molecule of interest [32,33], it is 
possible to scan the subject sooner, as there is no need to wait for unbound contrast agent 
to be washed out.  
Among the most commonly used MR CAs (gadolinium, ferric iron, and manganese), 
only iron particles are ferrimagnetic and produce an effect that involves an area 
substantially greater than its localization [34-36]. Even small quantities of iron oxide 
particles can therefore be detected on MR scans. In some cases, even a single particle or 
cell can be detected [37-39].  
At present, in most experiments iron oxide particles are the preferred agents, as they 
provide sufficient relaxivity to reliably detect even minute concentrations of CA. 
Engineering of CAs based on their physicochemical properties therefore greatly 
influences in vivo MR detection. Meticulous considerations to these characteristics will 
ensure significant improvements in the application of molecular imaging agents [36]. 
Although design and engineering of the CAs are developing, one of the greatest 
challenges over the coming years will be to ensure that these exciting advances find their 
translation into clinical applications. Not only the preclinical studies are needed to 
determine the feasibility and reliability of the novel CAs, but also prior to implementation 
in human subjects the safety of the newly engineered agents needs to be evaluated [28]. 
The use of CAs to visualize intracellular targets or to use them for cellular MRI 
especially needs to be thoroughly assessed, because they will remain localized to the 
compartments for considerably longer time frames compared to the current conventional 
MRI agents [30]. 
Molecular/cellular MRI is an interdisciplinary field of study that requires highly 
specialized expertise in CA chemistry, MR physics, image analysis, and biological 
disciplines.  
 
2.3.2 Positive and Negative CAs 
 
Using most conventional pulse sequences, T1 agents give rise to increases in MR 
signal intensity and therefore they are also called positive contrast agents. On the other 
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hand, T2 agents largely increase l/T2 of tissue, hence leading to a decrease of the signal 
intensity and are classified as negative contrast agents. Paramagnetic materials increase 
1/T1 and l/T2 approximately equally, whereas superparamagnetic agents predominantly 
increase 1/T2. Paramagnetic agents include substances with one or more unpaired 
electrons, such as molecular nitric oxide, nitrogen dioxide, oxygen, or metal ions which 
have incomplete d or f orbital (mostly transition metal ions). Most of the transition metal 
ions alone are extremely toxic to the human body; therefore chelation of these ions with 
molecules such as diethylenetriamine-pentaacetic acid (DTPA) has been used to reduce 
their toxicity. 
Fig. 2.6 shows how negative (left) and positive (right) contrast agents give a better 
image contrast.  
 
 
 
 
 
 
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIG 2.6 Liver MR image (a) without and (b) with negative contrast agent. Arrows show the liver 
tumor. (c) an MR angiography using positive contrast agent.  
 
 
 
 
 
Figs. 2.6a and b illustrate MRI images of liver without and with the use of magnetic 
CA, respectively. The arrows show the position of the tumor. As one can see, although 
without any CA it is possible to see the tumor, the tumor is much better defined in 
a) 
b) 
c) 
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presence of CA. As the CA is uptaken by the normal Kupffer cells, the signal of the 
normal tissues decreases and a better negative contrast is obtained. Fig. 2.6c, shows the 
effect of using a positive contrast agent. It is easily seen that the positive contrast agent 
increases the signal intensity of the vessels circuit resulting in seeing the area of interest 
brighter.    
Gd-DTPA represents the first generation of MR contrast agents, introduced in the 
1980s. This paramagnetic complex enhances predominantly the T1 relaxation rate of 
protons mainly through the inner sphere (see next section) relaxation [40]. Gd-DTPA has 
shown useful enhancement of the MR image contrast of the central nervous system [41-
43]. A typical dosage required for effective contrast enhancement using this type of 
agents is approximately 10-4 M. This concentration is lower than that of conventional 
iodinated radiographic contrast media for which 10-2 M is an effective concentration, but 
higher than the effective concentration needed for radiopharmaceuticals (< 10-7 M). 
Research on superparamagnetic pharmaceuticals, representing a second class of MR 
CAs, started in 1986. As already anticipated, these agents are particles with a much 
higher magnetic moment and they can significantly enhance the proton T2 relaxation rate 
(negative agents). Superparamagnetic agents include different types of inorganic iron 
particles which contain iron in different valence states and vary in their chemical 
composition, crystal structure, size and coating. 
Superparamagnetic particulates have a strong effect on the spin-spin (transverse) 
relaxation process of the nearby protons. The relaxation mechanism of these agents is a 
complex process which has been the topic of several papers, and remains an active area 
of research. 
Differently from paramagnetic chelates, the superparamagnetic particulates have a 
much higher magnetic moment. The large magnetic moments of these particulates in a 
magnetic field generate local field inhomogeneities. It is thought that as the protons 
diffuse near these field inhomogeneities, their Larmor frequencies lose coherence of 
phase, therefore causing an increase in transverse relaxation rate of protons. 
A high magnetic susceptibility, i.e. the ability to cause strong inhomogeities in the 
magnetic field, is desirable for a MR CA because it can significantly reduce the dosage 
required for sufficient contrast enhancement, thereby reducing its toxicity risk. 
 
2.4 Relaxation Mechanisms of CAs 
 
As mentioned previously, even though the intrinsic MRI contrast is much more 
flexible than in other clinical imaging techniques, the diagnosis of several pathologies 
requires the involvement of CAs that can enhance the difference between normal and 
diseased tissues by modifying their intrinsic parameters. This is the result of increasing 
(positive agents like paramagnetic CAs) or of decreasing (negative agents like 
superparamagnetic CAs) the signal intensity by shortening the proton relaxation times of 
the imaged organs and tissues. Accordingly, MR CAs are "indirect" agents because that 
is not the CA which becomes visible in the imaging as opposed to other imaging 
contrasts.  
The signal produced by MRI CAs (i.e. the CAs’ efficiency) depends on their spin-
lattice and spin-spin relaxivities r1 and r2, respectively, which are defined as the increase 
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of relaxation rate produced by 1 mmol per liter of magnetic center (expressed in s-1 
mmol-1 l) [44]. The r1 and r2 are the main physicochemical parameters that are considered 
in the development of an effective MRI CA. Relaxivity depends essentially on the size 
and chemical structure of a molecule and on the accessibility of water molecules to the 
magnetic center which is defined as: 
 
                                               (1/ ) (1/ ) /i i s i dr T T C                                              2.16 
 
Where i = 1, 2, C is the magnetic center concentration in the sample (in mM), (1/Ti) 
are the nuclear relaxation rates and the suffixes s and d stand for sample and dispersant.  
It should be emphasized that the concentration of CA in the tissue is not the only 
parameter that contributes to its efficiency. The CA distribution within the image voxel, 
the proton density, the diffusion, and the chemical environment give crucial contributions 
to the signal enhancement/depression for T1- or T2- relaxing agents, respectively. 
 
2.4.1 Paramagnetic Relaxation 
 
Quantitative and heuristic theoretical models to express the nuclear relaxivity induced 
by paramagnetic centers have been developed. The efficiency of CAs is related to 
molecular motions and to intrinsic properties of the molecules (magnetic moment, 
gyromagnetic ratio, spin). 
The paramagnetic relaxation is classically explained by two mechanisms: 1) the inner 
sphere (IS) and 2) the outer sphere (OS) contributions [44]. The principle of inner sphere 
relaxation (shown in Fig 2.7) relies on a chemical exchange during which one or several 
water molecules, belonging to the CA, leave the first coordination sphere of the magnetic 
compound and are replaced by the molecules of the bulk water (residence or exchange 
time M ).   
This mechanism allows the propagation of the paramagnetic effect to the totality of the 
solvent. The IS model has been described by the Solomon-Bloembergen-Morgan theory 
(SBM) [45,46]. The relaxation time of water protons located in the first coordination 
sphere of the metal is T1M. The contribution of the inner sphere mechanism is thus given 
by: 
 
                                                  1
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T                                                      2.17 
 
where: 
f = the relative concentration of the paramagnetic complex to the water molecules; 
q = the number of water molecules in the first coordination sphere; 
M  = the water residence time; 
Calculation of T1M is based on a model which includes the amplitude of the magnetic 
interaction, its temporal modulation and the effect of the strength of the external magnetic 
field. From a complete model (Solomon-Bloembergen equation) it was found that: 
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 FIG. 2.7 Schematic representation of the inner sphere relaxation mechanism. 
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where: 
S  and H  = the gyromagnetic ratios of the electron (S) and of the proton (H), 
respectively; 
,S H  = the angular frequencies of the electron and of the proton; 
r = the distance between coordinated water protons and unpaired electron spins; 
1,2c  = the correlation times modulating the interaction; 
R  = the rotational correlation time of the hydrated complex (due to the Brownian 
motion); 
1,2S  = the longitudinal and transverse relaxation times of the electron; 
These latter parameters are field dependent: 
0S  = the value of 1,2S  at zero field; 
V  = the correlation time characteristic of the electronic relaxation times; 
The second contribution to the paramagnetic relaxation is the OS relaxation (Fig. 2.8). 
The main contribution to the nuclear relaxation rate increase from the OS mechanism 
comes from the fluctuations of the dipolar interaction acting at long-distance between the 
spin of the paramagnetic substance and the nuclear spin of bulk water protons. This 
mechanism is modulated by the translational correlation time ( D ) that takes into account 
the relative diffusion (D) of the paramagnetic center and the solvent molecule, as well as 
their distance of closest approach (d). The OS model has been described by Freed [47], 
assuming that the diffusion time is given by: 
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The complexity of equations describing the relaxation rate reveals the high number of 
parameters describing the IS and OS relaxation (eight parameters: 
0, , , , , , ,M R V Sq D r d    ). Considering this high number of parameters, the estimation of 
all of them by the technique of field cycling (this technique will be explained in the next 
chapter) is often ambiguous. Thus, the determination of some parameters by independent 
methods facilitates the theoretical adjustment of the theoretical fitting of the proton 
nuclear magnetic relaxation dispersion (NMRD) profiles (Fig. 2.9). This curve 
characterizes the efficiency of CA at different magnetic fields [48-52]. 
The most important parameters involved in the relaxation mechanism are: 
Rotational correlation time ( R ). The rotational correlation time characterizes the 
relative reorientation of the electron spin vector of Gd3+ and the nuclear spin vector of 
protons of the water molecule. Generally, for a low molecular weight complex, R  limits 
the relaxivity of the complex at imaging field. The rotational correlation time can be 
obtained by various methods, such as: 1) analysis of 17O longitudinal relaxation on Gd 
complexes [53,54], 2) measurement of the longitudinal relaxation rate in 13C-NMR [55], 
3) fluorescence polarization spectroscopy [56], and 4) 2H NMR on deuterated lanthanum 
complexes [48]. 
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 FIG. 2.8 Schematic representation of the outer sphere relaxation mechanism. 
 
 
 
 
 
 FIG. 2.9 NMRD profile of Gd-DTPA at 310 K (Laurent et al. 2006). 
 
 
 
 
 
Electronic relaxation times ( 1S  and 2S ). Longitudinal and transverse electronic 
relaxation times ( 1S  and 2S , respectively) describe the process of relaxation of the 
magnetization associated to electrons during transitions between electronic levels of 
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paramagnetic center. These transitions produce fluctuations of the dipolar nuclear-
electron interaction that allows the increase of the relaxation rate of protons. 
Number of coordinated water molecules (q). The number of coordinated water 
molecules strongly influences the IS contribution. For complexes like Gd-DTPA, if the 
number of coordinated water molecules increases from 1 to 2, the relaxivity increases by 
approximately 30%, but nearly all Gd-DTPA derivatives have a q value equal to 1. The 
value of q can be estimated either in solid phase (X-rays or neutron diffraction) or in 
solution [fluorescence of Eu or Yb complexes, LIS (lanthanide-induced shift) method in 
17O-NMR]. 
Proton-metal distance (r). In the presence of paramagnetic centers, the IS contribution 
relies on dipolar interactions. The efficiency of dipolar mechanism is proportional to 1/r6, 
where r is the metal-water proton distance. So, even a weak modification of this distance 
has an important impact on the complex relaxivity. 
Coordinated water residence time ( M ). The mechanism of IS relaxation is based on 
an exchange between bulk water molecules surrounding the complex and the water 
molecule(s) coordinated to the lanthanide. Consequently, the exchange rate ( 1/ex Mk  ) 
is an essential parameter for transmission of the “relaxing” effect to the solvent. This 
parameter has been studied in many complexes to understand the influence of various 
factors, like the charge, the presence of amide bonds, etc. [53,54,57-62]. 
 
 
2.4.2 Superparamagnetic Relaxation 
 
The proton relaxation in superparamagnetic colloids like iron oxide particles occurs 
because of the fluctuations of the dipolar magnetic coupling between the nanocrystal 
magnetization M and the proton spin of the bulk water due to the diffusion motion of the 
water along the sample and to the fluctuations of M as a consequence of the Neel 
relaxation process. These two mechanisms are both weighted by the "effective" magnetic 
moment of the nanocrystal, i.e. the squared Langevin function whose variation with H is 
crucial for determining the frequency where the nuclear relaxation rate reaches its 
maximum. These superparamagnetic crystals of iron oxides exhibit extremely high 
magnetic moments due to a cooperative alignment of the electronic spins of the 
individual paramagnetic ions. 
The nuclear relaxation is described by an OS model where the above mentioned 
dipolar interaction fluctuates because of both the translational diffusion process and the 
Nèel relaxation process [63-68]. The analysis of the proton NMRD profiles (see Fig 2.10) 
of superparamagnetic particles gives [69]: 
1. The average hydrodynamic radius (r): at high magnetic fields, the relaxation rate 
depends only on D  and the inflection point corresponds to the condition . 1I D   . The 
determination of D , 2 /D r D  , gives the crystal size. r, D and I  are the average 
radius of the superparamagnetic crystals, the relative diffusion coefficient, and the proton 
Larmor frequency, respectively. 
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 FIG. 2.10 NMRD profile of magnetite particles in colloidal solution. 
2. The specific magnetization (Ms): at high magnetic fields, Ms can be obtained from 
the equation 1/2max( / . )s DM R C  , where C is a constant and Rmax the maximal relaxation 
rate. 
 
 
 
3. The crystal anisotropy energy (Ea): the absence or the presence of an inflection 
point at low fields informs about the magnitude of the anisotropy energy. For crystals 
characterized by a high Ea value as compared to the thermal energy kBT, the low field 
dispersion disappears. This has been confirmed with cobalt ferrites [65], which are 
known to have high anisotropy energy. 
4. The Néel relaxation time ( N ): this correlation time characterizes the fluctuations of 
the total magnetization of the superparamagnetic particle. The relaxation rate at very low 
field R0 is governed by a “zero magnetic field” correlation time 0C , which is equal to N  
if N D  . However, this situation is not often met, so that N  is often reported as a 
qualitative value in addition to the crystal size and the specific magnetization, or deduced 
from magnetization and ac susceptibility data. 
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3.1 Samples 
 
The revolution in nanotechnology has brought us new tools not only in analytical 
systems but also for human applications. One of these new tools are the magnetic 
nanoparticles (MNPs) [1,2]. Because of their ultrafine size, biocompatibility, and 
superparamagnetic properties, iron oxide nanoparticles are already approved for various 
biomedical applications such as enhanced contrast magnetic resonance imaging [3] and 
cellular labeling/cell separation [4-7] and are undergoing preclinical and clinical 
evaluation for applications such as drug delivery [8-14], cell and tissue targeting [15], 
transfection [16,17], and magnetic hyperthermia [18]. Superparamagnetic iron oxide 
nanoparticles (SPIONs) with a mean particle diameter of about 10 nm suspended in 
appropriate carrier liquids are commonly called ferrofluids and have outstanding 
properties. Each particle contains only a single magnetic domain and can thus be treated 
as a small thermally agitated magnet in the carrier liquid. The special feature of 
ferrofluids is the combination of normal liquid behavior with superparamagnetic 
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properties. This enables the use of magnetic forces for the control of properties and flow 
of the liquids, giving rise to numerous technical applications. Especially for in vivo 
applications, such as drug delivery, superparamagnetism is crucial because once the 
external magnetic field is removed, the magnetization disappears. Therefore, 
agglomeration and hence the possible embolization of the capillary vessels, can not take 
place [19]. However, two major shortcomings encountered in the in vivo application of 
superparamagnetic particles are their destabilization due to the adsorption of plasma 
proteins and their nonspecific uptake by the reticulo-endothelial system (RES; phagocytic 
cells residing in tissues forming part of the body’s immune system) [20,21]. Because of 
the high specific surface area of the nanosized particles, plasma proteins interact with the 
particles, causing an increase in the particle size and often resulting in agglomeration. 
The particles are also considered as intruders by the innate immune system and can be 
readily recognized and engulfed by macrophage cells that may cause agglomeration. In 
both cases, the particles will be removed from the blood circulation, which will yield a 
decrease in their effectiveness, leading to a reduction in efficiency of nanoparticle-based 
diagnostics and therapeutics. 
To prevent both phenomena and provide longer circulation times, the particles are 
usually coated with hydrophilic and biocompatible polymers/molecules such as 
polyethylene glycol (PEG), dextran, polyvinyl alcohol (PVA), poly(acrylic acid), 
chitosan, pullulan, or poly(ethyleneimine) (PEI) [22]. Furthermore, the immediate release 
of large amounts of the adsorbed/encapsulated drug, the so called burst effect, upon 
application into the body, an effect that is related to the high surface-to-volume ratio of 
nanoparticles, will cause a reduction of the amount of drug that reaches the targeted site. 
The other very important and challenging issue concerning the biomedical application 
of nanoparticles is the possibility of getting them functionalized. This may be made using 
different strategies, such as the addition of specific targeting ligands, dyes or therapeutic 
agents. Finctionalized nanoparticles will lead to design of multifunctional biomaterials 
for diagnostics (e.g. contrast agents in optical and MR imaging) and therapeutics (e.g. 
hyperthermia cancer treatment and targeted drug and gene delivery), the so called 
theranostics. Such particles would be able to identify disease states and simultaneously 
play the therapeutic role. 
Magnetic hyperthermia has recently attracted the attention of the scientist as a new 
way to treat cancer. It is based on the fact that magnetic nanoparticles, when subjected to 
an alternating magnetic field, produce heat. As a consequence, if magnetic nanoparticles 
are put inside a tumor and the whole patient is placed in an alternating magnetic field of 
well-chosen amplitude and frequency, the tumor temperature would raise. This could kill 
the tumor cells by necrosis if the temperature is above 45 °C, or could improve the 
efficiency of chemotherapy if the temperature is raised around 42 °C. This treatment is 
tested on humans only in Germany, but research is in progress in several laboratories 
around the world to test and develop this technique [18]. 
Targeted drug delivery is a method of medication delivery to a patient in a manner that 
increases the concentration of the medication in some parts of the body relative to others. 
The medication is distributed throughout the body through the systemic blood circulation. 
For most therapeutic agents, only a small portion of the medication reaches the organ to 
be affected. Targeted drug delivery tries to concentrate the medication in the tissues of 
interest while reducing the relative concentration of the medication in the remaining 
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tissues. This improves the efficiency andreduce the side effects. Targeted drug delivery 
can be used to treat many diseases, such as the cardiovascular diseases and diabetes. 
However, the most important application of targeted drug delivery is to treat the 
cancerous tumors. 
The regularly employed SPIONs in drug delivery consist of nanoparticles, 
nanospheres, liposomes and microspheres. In these systems, the drugs are bound to the 
SPIONs' surface (especially for NPs) or encapsulated in magnetic liposomes and 
microspheres. The most recent delivery systems are focused on anti-infective, blood clot 
dissolving, anti-infammatory, anti-arthritic, photodynamic therapy, and paralysis-
inducing drugs as well as on stem cell differentiating/tracking [23,24].  
The surface engineered SPIONs (e.g. with targeting ligand/molecules attached to their 
surfaces) used together with the aid of an external magnetic field are recognized as a 
modern technology to introduce particles to the desired site where the drug can be 
released. Such a system has the potential to minimize the side effects and the required 
dosage of the drugs [23,25,26]. However, once the surface-derivatized nanoparticles are 
inside the cells, the coating is likely digested leaving the bare particles exposed to other 
cellular components and organelles thereby potentially influencing the overall integrity of 
the cells [27,28]. It is hypothesized that rigid coatings such as crosslinked PEGF could 
postpone this shortcoming [27]. 
Relying on this introduction and knowing that polymers can provide a way to avoid 
agglomeration and easy surface functionalisation, we have studied magnetic and 
relaxometric properties of two different classes of samples, both of them showing 
superparamagnetic behaviors and coated with the polymers. We will introduce them in 
the followings. 
 
3.1.a Multifunctional Polymer-Based Nanostructured Bio-Ferrofluids: 
Multifunctional polymer-based nanostructured bio-ferrofluids (named samples A-D), 
hereafter in brief bio-ferrofluids, have been synthesized by our collaborator, Instituto de 
Ciencia de Materiales de Aragón, CSIC-Universidad de Zaragoza, in Spain (Prof. F. 
Palacio, Dr. A. Millan).  
The synthesis of the bio-ferrofluids was performed in two steps: 1) synthesis of 
maghemite/polyvinylpyridine (PVP) nanocomposites, and 2) synthesis of ferrofluids 
(using the nanocomposites) in a buffer saline solution (PBS) medium. Maghemite/PVP 
nanocomposites were prepared by in situ precipitation from iron–PVP coordination 
compounds, following the procedure described in [29]. A film of iron-polymer precursor 
was obtained by evaporation of a 50% water:acetone solution containing 0.2g of PVP 
(Aldrich, 60 kD), and variable amounts of FeBr2 (Aldrich) and FeBr3 (Aldrich). The 
precursor film was treated with 20mL of 1 M NaOH solution for 1h, washed with water 
and dried in open air to obtain a maghemite nanocomposite. The size of the maghemite 
nanoparticles in the composites was tuned by using different Fe(II)/Fe(III) and Fe/N 
ratios. Composites for samples A-C were prepared using a Fe(II)/Fe(III) ratio of 0.5 and 
Fe/N ratios of 0.5, 0.625 and 1 respectively. Composite for sample D was prepared using 
a ratio of 1 for both Fe(II)/Fe(III) and Fe/N. The ferrofluids were prepared according to 
Ref. 2. The maghemite/PVP nanocomposites were dispersed in an acidic solution at pH  
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3. The resulting acidic ferrofluid was mixed with 0.18 mL of polyethylenglycol (PEG) 
(MW=200D) acrylate (PEG(200)-A) (Monomer&Polymer), and 0.02g of PEG 
(MW=1000D) acrylate (PEG(1000)-A-COOH) (Monomer&Polymer), and was heated to 
70oC during 24h. Then, Na2HPO4 was added for a 0.01M final concentration, the pH was 
adjusted to 7.40 by addition of a 0.2M NaOH solution, and the ionic strength was 
adjusted to 0.15 by addition of NaCl and KCl. Finally, the dispersion was filtered through 
a 0.22m membrane filter to obtain a bio-ferrofluid. Scheme of bio-ferrofluids including 
the carboxyl group (-COOH), for getting them functionalized, is shown in Fig. 3.1. 
 
  
 
 
 
FIG. 3.1 Scheme of bio-ferrofluids dispersed in PBS with PEG coating and carboxyl group for making 
them functionalized.  
 
 
 
 
In vivo toxicology experiments, to study the effect of the bio-ferrofluids on mice, 
already have been done. A group of mice were injected with the maximum allowed 
volume of bio-ferrofluid with a concentration of 4 g/L of iron oxide. After one month, the 
mice did not show any anomaly and an analysis of the organs after being sacrificed did 
not revealed any damage nor a significant accumulation in the organs of the treated mice.   
The bio-ferrofluids have been also already used in haematology studies. They have not 
shown any problems with blood. In fact they show an effect that can be beneficial, i.e. 
they are anticoagulants. The coagulation effects of biocompatible multifunctionalizable 
bio-ferrofluids designed for biomedical applications have been studied. It has been found 
that the bio-ferrofluids not only do not cause coagulation, but also they act as non specific 
circulating anticoagulant agents in vitro and the results are going to be confirmed in vivo 
by a Ph.D. student in Spain. Therefore, the bio-ferrofluids, in addition to their inherent 
biomagnetic applications, could be also useful in other biomedical applications such as 
anticoagulant agents. 
-COOH
PEG  
(Polyethyleneglycol) 
Maghemite 
Phosphate Buffered Saline 
Solution (PBS) 
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They have also been used in cell experiments and low cytotoxicity in opossum kidney 
cells has been revealed and reported [30]. Bio-ferrofluids have been also functionalised 
with an optical dye (fluoresceine and rhodamine) attached to the surface of the particles 
which permits to track the pathway of the particles across the cellular membrane and 
inside the cell. It has been observed that the particles are internalized by the cells and 
they do not enter into organelles such as mitochondria, or ribosomes, but they accumulate 
in lysosomes. Thus the bio-ferrofluids could be also useful for the optical imaging. 
The hyperthermia efficiency of the samples also has been already investigated. The 
measurements have been done for several frequencies, in the frequency range 2 kHz to 
100 kHz, and several field intensities. The best performance has been obtained for the 
largest particle size (sample D) which is outstandingly larger than Endorem and 
substantially higher than ChemiCell (pure magnetite dispersed in water). 
The main idea is to use these samples as theranostics, i.e. simultaneous diagnostical 
and therapeutical, agents. Thus the study of their magnetic properties and MRI efficiency 
is a crucial issue. This is what we will report in the next chapter. 
 
3.1.b Superparamagnetic Colloidal Nano-Crystal Clusters (CNCs): 
Colloidal nano-crystal clusters (CNCs) are magnetic beads of several SPIONs with 
different polymer coatings. As a result of superparamagnetic behaviour, they present a 
large saturation magnetization, narrow size distribution, and no aggregation in solution. 
They have been synthesized by our collaborator, Institute for Nanoscience and 
Nanotechnology, Sharif University of Technology, in Iran (Dr. M. Mahmoudi).  
To synthesize the CNCs, iron salts (i.e., chloride) and sodium hydroxide (NaOH), with 
analytical grades, purchased from Merck Inc. (Darmstadt, Germany), were used without 
further purification. Polyvinyl alcohol (MW=30,000-40,000) was obtained from Fluka. 
PEG diol (MW 1 kDa), fumaryl chloride, calcium hydride and propylene oxide were all 
purchased from Aldrich (Milwaukee, MN, USA). Ammonium per-sulfate and methylene 
chloride (DCM) were obtained from Merck (Germany). Fumaryl chloride was purified by 
distillation at 161°C under ambient pressure. Tamoxifen (TMX) was obtained from 
Pharma Chemie Company (Tehran, Iran). Anhydrous DCM was obtained by distillation 
under reflux condition for 1h in the presence of calcium hydride. Other solvents were 
reagent grades and used without any further purification. 
Preparation of superparamagnetic iron oxide nanoparticles (SPIONs). SPIONs were 
prepared via the well known co-precipitation method, which was optimized previously 
[31]. Typically, iron salts (the mole fraction of Fe2+ to Fe3+ was adjusted to 1:2) were 
dissolved in Deionized (DI) water containing 0.5M HCL and all solutions were 
deoxygenated by the bubbling process with argon gas. The magnetite nanoparticles were 
precipitated by drop wise addition of iron salt solutions to NaOH solutions (with various 
molarities) under an argon atmosphere. In order to control mass transfer, which may 
allow particles to combine and build larger polycrystalline particles, turbulent flow was 
created by placing the reaction flask in an ultrasonic bath and changing the 
homogeneization rates during the first 2 minutes of the reaction [32]. It is notable that the 
stirring rate was fixed at 9000 rpm for all samples in the synthesis period (1h). Various 
molarities of the NaOH solutions (1, 2, 3, and 4) were examined. The particles were 
collected by external magnetic field and re-dispersed in DI water.  
Preparation of PVA-coated SPIONs. A Polyvinyl Alcohol (PVA) was dissolved in DI 
water and was added to the alkaline solution before introducing the iron salts. Then the 
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same method for SPIONs preparatin was employed in order to obtain coated 
nanoparticles.   
Preparation of poly(ethylene glycol)-co-fumarate (PEGF). The Temenoff method was 
used for the preparation of PEGF macromer [32]. Commonly, 0.03 mole of PEG diol was 
dissolved in 100ml of anhydrous methylene chloride (DCM) in a three-necked 250ml 
reaction flask equipped with a reflux condenser and a magnetic stirrer. Propylene oxide 
was employed as a catalyst for binding to the HCl, which is produced during the 
polymerization. The purified fumaryl chloride was dissolved in 50 ml of DCM and added 
dropwise in 1h to the stirred reaction flask at -2°C under nitrogen atmosphere. 
Consequently, the reaction temperature was enhanced to room temperature and run 
overnight. In order to remove the by-product (e.g., chlorinated propanols), the product 
was washed with 0.1N NaOH several times. The PEGF macromer was then obtained by 
rotaevaporation, dried at 25°C in vacuum for 24h, and then stored at -15°C until further 
use. 
Preparation of crosslinked-PEGF-coated SPIONs. The obtained PEGF solution was 
diluted in DI water and was added to the alkaline solution before introducing the iron 
salts. Then the same method for SPIONs preparation was employed in order to obtain 
coated nanoparticles. The coated-SPIONs were then collected by external magnetic field 
and re-dispersed in DI water in order to remove the unbounded polymers. The 
crosslinking of the unsaturated coating were started by Ammonium persulphate 
[(NH4)2S2O8] as initiator system [33] and an optimized amount of accelerator 
(DMAEMA) [34] via the redox polymerization. After stirring for 2h, the particles were 
washed several times and were kept at 4°C for future use. Schematic representative of the 
various synthesized magnetic nanoparticles are shown in Fig 3.2. 
Drug release. The drug release from nanoparticles has been investigated [34]. The 
study revealed that by introducing a crosslinking agent to the system, the burst effect was 
reduced by 21%. Thus the crosslinked magnetic nanoparticles are able to control the burst 
effect (see the results in the next chapter). 
Biocompatibility. To study the biocompatibility of the samples, the 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay has been made for 
L929 and K562 cells exposed to all the samples. All of them demonstrated acceptable 
levels of cell viability following exposure up to 400 mM, with none demonstrating toxic 
effects at the concentrations tested. In addition, the PEGF coated samples have shown 
more biocompatiblity than the PVA coated ones [34]. Therefore, the coosslinked-PEGF 
coated magnetic nanopartices would be very promising materials for the therapeutics, i.e. 
targeted drug delivery, applications. The results of MMT assay are reported in the next 
chapter. 
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FIG. 3.2 Schemes of the various synthesized magnetic nanoparticles including (a) single coated 
SPION, (b) (PVA) coated SPIONs, (c) crosslinked coated SPION, and (d) PVA- and crosslinked PEGF- 
coated CNCs. 
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To apply these materials in vivo, one has to be able to track them in the body. 
Therefore, their magnetic properties and the MRI efficiency should be studied. This is 
what we have investigated to see if they would be novel candidates to be introduced for 
the theranostics applications.   
  
3.2 Magnetic Properties 
 
3.2.1 SQUID-Based Magnetometers 
A superconductiong quantum intereface device (SQUID) magnetometer combines 
several superconducting components, superconducting magnet, detection coils, flux 
transformer, and superconducting shields. To make a measurement, a sample, typically 
less than a few millimeters in size, is first attached to a sample rod. The sample is then 
moved through the center of a first- or second-order superconducting gradiometer (see 
Fig. 3.3).  
 
 
 
 
 
 
FIG. 3.3 (a) Schematic of SQUID magnetometer, (b) Calibrated output from SQUID electronics, recorded 
as a function of position. 
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The gradiometer forms a closed flux transformer that is coupled to a SQUID and the 
signal from the SQUID is typically recorded as a function of sample position. The shape 
and magnitude of the response curve can then be analyzed using a computer to obtain a 
corresponding magnetic moment. The detection coils are located in the bore of a 
superconducting magnet by which an external static (or dynamic) magnetic field can be 
applied. Temperature control is made possible by placing the sample and sample rod in a 
sealed variable temperature insert (not shown in Fig 3.3) which is thermally isolated from 
the 4.2K gradiometer and magnet by an annular vacuum space. 
Because a SQUID magnetometer requires a liquid helium cryostat to cool the SQUID, 
it is relatively little additional expense to provide a superconducting magnet system and 
helium gas-flow temperature control. As a result, SQUID magnetometer systems 
typically offer the ability to measure in applied fields of up to 7T over a temperature 
range from above room temperature down to below 2K. 
As shown in Fig. 3.4, we have used a Magnetic Property Measurement System 
(MPMS) XL by Quantum Design (QD). Fig. 3.5 shows a schematic cross-section of the 
QD MPMS-XL. The 9-mm diameter sample chamber is cooled by liquid helium that is 
drawn through a pair of capillary tubes connected to the bottom of the chamber. One 
capillary is high-flow and thermally switched for rapid cooling. The other enables 
continuous-filling pumped-helium operation to below 2K. In operation, cold gas is 
pumped out of the top of the cryostat through the annular space between the sample 
chamber and the vacuum sleeve, thus cooling the sample chamber. Heaters and 
thermometers on the sample chamber (not shown in Fig 3.5) provide temperature control 
up to 400K. Lower section of the sample chamber is wrapped with the copper wires (coil-
foil)  for temperature uniformity in the region of the sample with minimal eddy current 
induction.  
A linear motor attached to the sample rod at the top of the dewar is used to move the 
sample smoothly within the detection coils. To prevent contamination of the helium 
exchange gas in the sample chamber, a sliding seal is required if the motor is outside the 
chamber volume. An alternative is to include the motor and gearing mechanism in the 
vacuum space. For measuring magnetic anisotropy, a sample rotator is used to rotate the 
sample in situ about a horizontal axis. A different rotator is used to rotate about a vertical 
axis when the system is configured with optional transverse (saddle) pickup coils. 
The MPMS uses an rf SQUID, operating at a 150MHz bias frequency with a 
modulation frequency of 100 kHz, in a flux-locked loop. Rf SQUIDs were initially 
selected for the first MPMS systems because they were cheaper and more readily 
available than dc SQUIDs. Later, MPMS systems continued to use rf SQUIDs for 
compatibility with the existing design and control system.  
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FIG. 3.4 Magnetic Property Measurement System (MPMS) XL; (a) computer and cabinet for gas handling 
and all control electronics, (b) cabinet for dewar. 
 
 
FIG. 3.5 Schematic cross-section of the MPMS. 
(a) 
(b) 
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The design and construction of the detection coil are optimized to provide 
measurement sensitivity, accuracy, and noise immunity, given the mechanical constraints 
imposed by the other components of the system (e.g., vacuum sleeve). A second-order 
gradiometer design is used because it significantly reduces noise contributions from both 
flux motion in the magnet and from the environment with an order of magnitude 
improvement compared to a first-order gradiometer [35]. A longitudinal gradiometer 
(shown in Fig. 3.3) detects moments parallel to the applied field, while an optional 
transverse detection configuration is available that uses saddle coils. The magnet and 
gradiometer are mechanically rigid to reduce the effects from vibrations, allowing 
subpicotesla magnetometer sensitivity in tesla-strength fields. In the absence of a vacuum 
sleeve, the diameter of the detection coils could be optimized for specific sample sizes 
with a diameter that is small enough for good coupling and large enough that accuracy is 
not affected by the geometry of the sample. In the MPMS, the smallest diameter coils 
(20.2 mm) are used which fit on the outside of the vacuum sleeve. Once the coil diameter 
is determined, the baseline of the gradiometer is optimized for on-axis sensitivity while 
adequately rejecting field noise from the magnet and environment. 
A SQUID magnetometer system is uniquely adapted to measuring static (dc) 
magnetization of samples. However, as a general technique for studying magnetic 
properties, this type of measurement is limited in that it does not directly reveal 
dynamical information about the magnetic properties of materials. To do that, a dynamic 
(ac) susceptibility measurement is generally required.  
With an ac susceptometer, a small oscillating field is added to the applied field and a 
lock-in amplifier used to measure the complex differential susceptibility /ac dM dH  , 
where M and H are the magnetization and the total applied field, respectively. Because 
the measurement is narrow-band, sensitivity is greatly enhanced over a comparable dc 
technique. At low enough frequencies and small enough oscillation amplitudes, ac  is 
real and equal to the slope of the magnetization curve. However, in general there is an 
imaginary part that contains dynamical information that cannot be found from 
measurements of the static magnetization. 
Most non-SQUID magnetometer systems use mutual inductance bridges [36] and are 
limited to frequencies above a few hertz, because the induced signal is proportional to 
frequency. When configured for ac magnetization measurements, the MPMS has a flat 
sensitivity of 125 10  Am2 down to below 0.1Hz. On the MPMS system, the ac 
measurement capability is provided by adding: (1) a separate excitation coil in the bore of 
the main magnet and (2) electronics capable of driving the excitation coil while also 
applying a synchronous compensation signal directly to the gradiometer feedback 
transformer. An oscillating applied field can be produced which ranges in amplitude from 
0.1 to 400.0 μTesla for frequencies from 0.1 to 1000Hz, on a bias field of ±7 Tesla. The 
compensation signal is required because measurements are performed on the most 
sensitive SQUID range possible. Without the compensation, the 0.1 to 0.2% gradiometer 
imbalance would couple too much flux directly from the excitation coil. 
The system performs the following steps during an ac measurement. First, the sample 
is positioned in the middle of the lower side coil and the SQUID is then nulled. Nulling 
involves determining and setting the amplitude and phase of the 50/60Hz line 
compensation signal that needs to be injected into the feedback circuit. In addition, a 
compensation signal is determined and applied to the feedback circuit that reduces the 
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direct coupling of the oscillating field into the imperfect gradiometer. Next, the detected 
waveform is digitized. Finally, the sample is moved to the center of the gradiometer and 
the signal again digitized. A subtraction of the two measurements, properly weighted for 
the detection coil response function, removes any residual direct coupling between the 
drive and the detected signal [37]. 
Because both the drive field and detection coils are outside the sample tube and 
vacuum sleeve, the effects of eddy currents and the magnetic susceptibility of the tube 
must be considered. In the MPMS a highly resistive copper alloy with nearly 
temperature- and field-independent susceptibility, is used for constructing the tubes. 
Careful frequency-dependent calibration of amplitudes and phase shifts is still required. 
A further calibration is required to compensate for both field- and frequency-dependent 
screening of the applied field by the superconducting magnet windings and 
magnetoresistive effects in the surrounding materials [37]. 
This technique is very sensitive to differential susceptibility as a function of field and 
so can detect very weak phase transitions on top of weak background signals. The 
imaginary component reveals the time-dependent magnetic behavior of spin glasses, 
superparamagnetic particles, domain-wall motion in ferromagnets, flux motion in 
superconductors, and other dissipative phenomena in materials.  
 
3.2.1.a Bio-Ferrofluids 
The magnetic properties of the bio-ferrofluids were studied by means of dc 
magnetization as a function of field at room temperature and ac magnetic susceptibility 
measurements as a function of temperature and frequency in a MPMS-XL SQUID 
magnetometer from Quantum Design. The results are presented in the next chapter. 
 
3.2.1.b CNCs 
Magnetization measurements of CNCs have been performed on the solid (dry powder) 
samples using a SQUID dc magnetometer, MPMS-XL7. The temperature dependence of 
the magnetization has been studied in the temperature range 2-300 K by zero-field-
cooling (ZFC) and field-cooling (FC) curves at H=10mTesla applied magnetic field. To 
investigate the behavior of the magnetization as a function of applied magnetic field, 
hysteresis experiments in the range of -5Tesla  H  +5Tesla have been performed at 
both T=2 K and T=300 K. The results are reported in the next chapter.  
 
3.2.2 NMR Relaxometers 
For studying the relaxometric properties of the samples, we have measured T1 and T2 
of all samples at room temperature by employing both conventional and Fast-Field-
Cycling (FFC) NMR spectrometers. 
The 1H NMR technique was employed to measure the longitudinal and transverse 
relaxivities in a wide range of frequencies covering most of the clinical imagers (  8.5, 
21 and 63 MHz corresponding to about 0.2, 0.5 and 1.5 T respectively). For  > 10 MHz 
a Stelar Spinmaster and an Apollo-Tecmag spectrometers have been used. Standard 
radiofrequency excitation sequences CPMG-like and saturation-recovery were applied to 
determine T2 and T1 values.  
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For 10 kHz    10 MHz, the NMR data were collected with a Smartracer Stelar 
relaxometer using the FFC technique. The conventional spectrometers are widely used 
and well known to the people. In the following we will introduce briefly the principles of 
the FFC relaxometry.  
FFC Relaxometry is a NMR technique used to determine T1 relaxation time over a 
range of B0-fields spanning about 6 decades, from about 10-6 Tesla up to ~1 Tesla. The 
boundaries of this range are not well defined: the lower limit is set by the local fields; the 
upper limit is chiefly determined by technical choices and compromises. This enormous 
range should be compared with the 0.1 Tesla to 20 Tesla intervals currently covered by 
standard NMR superconductor magnets and electromagnets. However, studies of T1 
dispersion curve with an array of standard magnets is impractical, and the usefulness of 
T1ρ is limited by subtle differences relative to T1 and technical problems at high B1 fields 
(overheating of the sample, phase shifts of the transmitter during long pulses). On the 
other hand, FFC requires a specialized system, which does not compete with the 
sensitivity and resolution of most NMR spectrometers. 
In practice, FFC is a convenient and, sometimes, unique method to follow over 
extended temperature intervals, the dynamics of "coupled" systems such as liquid 
crystals, polymers, biomolecules, viscous fluids and glasses, solid electrolytes and, in 
general, solids with "slow" or correlated motions [38,39]. 
A typical field cycle is schematically presented in Fig. 3.6. As one can see in Fig. 3.6, 
the basic field cycling experiments ideally consists of three steps: 
1. The sample is polarized in a high field for a time tp until the nuclear 
magnetization achieves saturation, i.e. tp should be longer than 4 times T1 at 
Bp (field of polarization). 
2. The magnetic field is switched to a value Br (field of relaxation) for a time tr 
during which the magnetization relaxes towards a new equilibrium value.  
3. The magnetic field is switched to a value Bd (field of detection) and the 
equilibrium magnetization is measured with a 90° pulse followed by 
acquisition. 
These steps are repeated for a set of tr values until the T1 value at Br is determined; 
then, a new Br value is selected and the corresponding T1 is measured. 
Quantitatively, the polarization field Bp should be as high as possible to increase 
magnetization and SNR. To analyze "fast" relaxation phenomena, we should be able to 
switch to Br and to Bd in "short" times. Differently from Bp and Br, the detection field Bd 
has to be "stable" and "homogeneous". Choosing the Bd as high as possible gives higher 
sensitivity.   
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FIG. 3.6 Schematic representation of a typical field cycle. 
 
 
Due to the different requirements of these fields, it would appear reasonable to 
perform the experiment by adding/subtracting a time-modulated field to a stationary, and 
homogeneous, detection field. However, when Br approaches zero, the time-modulated 
field should match the value, the homogeneity, and the stability, of the detection field. 
This means that, with or without a stationary field, top performances essentially require 
that a homogeneous field is rapidly switched between two values. Nearly universally, this 
goal has been achieved with a resistive solenoid connected with a suitable power supply 
and cooling system. 
A Block diagram of a typical FFC relaxometer is shown in Fig. 3.7. 
 
 
 
 
 
FIG. 3.7 Block diagram of a typical FFC relaxometer. 
Chapter III: Materials and Methods 61 
The general FFC pulse sequence is shown in Fig. 3.8 which is suitable for the 
measurement when the difference of Bp and Br is sufficiently large. For the case of high 
Br, it is more favorable to start the cycle in the absence of any polarization field. 
Therefore, field cycling relaxometry contains basically the pre-polarized (PP) sequence 
for the measurements at low fields and the non-polarized (NP) sequence for the 
measurements at high fields (see Fig. 3.8). 
 
 
 
 
 
FIG. 3.8 Two basic types of field sequences with the 90
o 
rf pulse used in the field cycling measurement, a) 
basic pre-polarized (PP) sequence and b) basic non-polarized (NP) sequence. 
 
 
 
 
 
For the measurements of T1 we used both PP  (bellow 3MHz) and NP (above 3MHz) 
sequences. For T2 measurements, since we run the experiments for the frequencies above 
4MHz, we employed NP-CPMG sequence.  
 
3.2.2.a Bio-Ferrofluids 
The 1H NMR technique was employed to measure the longitudinal and transverse 
relaxivities in a wide range of frequencies covering most of the clinical imagers (  8.5, 
21 and 63MHz corresponding to 0.2, 0.5 and 1.5 Tesla respectively).  
For 10kHz10MHz, the NMR data were collected with a Smartracer Stelar 
relaxometer using the FFC technique [38,39], while for >10MHz a Stelar Spinmaster 
and an Apollo-Tecmag spectrometers have been used. Standard radio frequency 
excitation sequences CPMG-like and saturation-recovery were applied to determine T2 
and T1 values, respectively.  
 
3.2.2.b CNCs 
The 1H NMRD profiles were determined, at room temperature, by measuring the 
longitudinal T1 and transverse T2 nuclear relaxation times, in the frequency range              
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10KHz    64MHz for T1 and 4MHz    64MHz for T2. The frequency ranges cover 
the typical frequencies of the MRI clinical imagers, i.e. 8.5, 21, 63 MHz, 
corresponding to the magnetic fields 0.2, 0.5 and 1.5 Tesla. 
For the frequency range 10KHz    10MHz, the NMR data were collected with a 
Smartracer Stelar relaxometer using the FFC technique [38,39] while for >10MHz a 
Stelar Spinmaster spectrometer has been employed. Standard radio frequency excitation 
sequences CPMG-like and saturation-recovery were applied to determine T2 and T1 
values, respectively. 
 
3.2.3 MRI Scanner 
A schematic presentation of the conventional MRI scanner is shown in Fig. 3.9. More 
details about the MRI technique and the magnetic field gradients are given in Appendix 
A. 
In vitro MRI experiments were performed at 8.5 MHz, i.e., 0.2 Tesla, using an 
Artoscan Imager by Esaote S.p.A. which is presented in Fig. 3.10.  
 
 
 
 
 
 
 
 
 
FIG. 3.9 Schematically representation of a conventional MRI scanner. 
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FIG. 3.10 Schematically representation of an Artoscan Imager by Esaote S.p.A. 
 
 
 
For performing the experiments, we prepared Endorem and our samples with the same 
concentration, namely 0.02 mg/ml, and put each of them in a separate vial. The 
experimental parameters for each set of samples are given in the following.   
 
3.2.3.a Bio-Ferrofluids 
In vitro MRI images for the bio-ferrofluids were performed using two pulse sequences 
programs: a) high resolution Gradient Echo (GE) with TR/TE/NEX=1000ms/16ms/4, 
matrix=256*192, FOV=180*180, flip angle=90o; and b) high resolution Spin Echo (SE) 
sequence with TR/TE/NEX=1000ms/26ms/4, matrix=192*192, FOV=180*180, number 
of slices=5 and slice thickness=5mm. The vials of samples were prepared with the same 
concentrations and put in the vials to perform the images. The obtained images are given 
in the next chapter. We remind here that TE is the distance between the first rf pulse and 
the echo maximum, TR is the repetition time of the sequence, NEX is the number of 
excitations (averages), FOV is the field of view, the matrix gives the number of sampling 
points in the (xy) plane.  
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3.2.3.b CNCs 
For the CNCs in vitro MRI experiments, we used a Spin Echo (SE) T2 pulse sequence 
with TR/TE/NEX=2000ms/80ms/1, matrix=256*192, FOV=180*180, number of 
slices=5, and slice thickness=4mm, as image parameters. The vials of samples were 
prepared with the same concentrations and put in the vials to perform the images. The 
obtained images are given in the next chapter. 
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4.1 Bio-Ferrofluids 
 
4.1.1 TEM and X-Ray Characterizations  
 
The characteristics of the ferrofluids are shown in Table 4.1. Transmission electron 
microscopy (TEM) images (Fig. 4.1) show a uniform distribution of iron oxide 
nanoparticles encapsulated in a continuous polymer film. Most of the particles are 
spherical with an average size that increases regularly from 7.4 nm (sample A) to 15 nm 
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(sample D) in relation to the Fe2O3/PVP and Fe(II)/Fe(III) ratios selected in the synthesis 
(Table 4.1). Electron Diffraction (ED) patterns on these particles are consistent with a 
maghemite crystal structure (central image in Fig. 4.1). A small number of particles are 
elongated. 
 
 
 
 
 
 
TABLE 4.1 Characteristics of the ferrofluid samples.  
Sample Fe2O3/ PVPa 
Fe(II)/ 
Fe(III)a 
DH 
(nm )b PDI
c      DP 
     (nm)d
SD 
(nm) 
TB 
(K)e
A 0.5 0.5 59 0.16 7.4 1.2 40 
B 0.625 0.5 62 0.18 8.6 2.0 45 
C 1 0.5 92 0.15 10.8 2.9 160 
D 1 0.9 93 0.14 15.0 3.7 200 
aMolar ratios used in the preparation of the sample; bHydrodynamic diameter; cPolydispersity index as 
obtained from Dynamic Light Scattering (DLS); dMaghemite particle diameter from TEM images; 
eBlocking temperature from AC magnetic susceptibility measurements at 30 Hz. 
 
 
 
 
 
 
 
FIG. 4.1 TEM images of samples A(a), B(b), C (c) and D (d) and a characteristic ED diffraction pattern 
of the particles. In sample D some of the crystals are faceted. 
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Distributions of the hydrodynamic sizes for the series of samples are shown in Fig. 
4.2. In all cases a monomodal distribution of particle diameters was found. The average 
hydrodynamic diameter DH increases with the iron oxide/polymer ratio (see Table 4.1) 
from 59 nm (sample A) to 92 nm (sample C), and it is hardly changing in samples with 
similar Fe2O3/PVP ratio but different particle size (samples C and D). 
The average sizes of magnetic nanoparticles (MNPs) found by TEM represent about 
10-15% of the average hydrodynamic sizes. Considering that at the pH of the medium 
(7.40) pyridine groups are hydrophobic and PEG residues are hydrophilic, then the 
structure of the MNP@PVP@PEG beads in suspension could be as follows: an inner part 
formed by a single folded PVP chain entrapping the MNPs by N-Fe coordination bonds, 
and an outer part formed by solvated PEG chains in a radial disposition.  
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FIG. 4.2 Distribution of the hydrodynamic sizes for the series of samples.  
 
 
 
 
 
 
4.1.2 SQUID Magnetometry 
 
The ac magnetic susceptibility as a function of temperature of samples A to D shows 
the characteristic behaviour of the superparamagnetic systems, with the in- and out-of-
phase components (   and  , respectively) depending on frequency and with   
having a maximum at blocking temperature TB (Fig. 4.3), which depends on the 
frequency of the applied magnetic field following an Arrhenius like function [1,2]. This 
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shows that at low temperatures the magnetic moment of the MNPs can not be reversed, i. 
e. it is not able to cross the anisotropy energy barrier Ea = KVP (K is the anisotropy 
constant characteristic of the material and VP is the volume of the MNPs) and follows the 
field. As temperature increases, the moments of the cores, i.e. MNPs, with lowest 
anisotropy energy start to reverse, being this process thermally activated and termed Néel 
relaxation. As expected from this model, at a given frequency, TB increases with DP (Fig. 
4.4). 
Below 273 K these water based bio-ferrofluids are frozen and thermal activation is the 
only mechanism available for reversal. At room temperature, the MNPs whose E is too 
high for the thermal activation to be effective (say Ea>kBT ) have the possibility to 
reverse by mechanical rotation in the fluid (Brownian relaxation mechanism). The on-set 
of this mechanism leads to a sudden increase of   in the samples with a relevant 
fraction of “large” nanoparticles (i. e. nanoparticles with Ea> kBT).  
From the plot of magnetization versus applied field (Fig. 4.5) it is evident that the 
magnetization increases with the particle size as previously found in maghemite/PVP 
composites [3]. Fitting these curves to a Langevin function [4] modified by adding a 
linear term, it is possible to conclude that the average magnetic moment of the particles 
increases with the MNPs sizes. This model assumes that the core of the MNPs behave as 
a single spin (with the same value for all MNPs), and that the magnetic moments, at the 
MNPs surface, have a linear behaviour with the field in the studied field range [3]. The 
linear term also accounts for the diamagnetic contribution of polymer coating and the 
fluid.  
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FIG. 4.3   vs. temperature for samples A to D. The TB increases with increasing average sizes.  
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FIG. 4.4 Blocking temperature as a function of magnetic core size. The TB increases with increasing 
average sizes.  
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FIG. 4.5 Magnetization per gram of iron oxide for the series of bio-ferrofluids. Lines correspond to 
fitting to a modified Langevin function. 
 
 
 
 
4.1.3 NMR Relaxometry 
 
To evaluate the MRI contrast efficiency of the samples, the nuclear longitudinal and 
transverse relaxivities (r1 and r2, respectively) were obtained from the spin-lattice T1 and 
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the spin-spin T2 relaxation times measured at room temperature. It is notable that for the 
bio-ferrofluids, PBS (at physiological pH) is the diamagnetic host solution.  
Endorem® (Feridex in the USA) is one of the well-known commercial 
superparamagnetic iron oxide MRI contrast agents coated with dextran for 
intravenous administration for the detection of liver lesions. The NMRD profiles for 
samples A to D and the Endorem® are shown in Fig 4.6. The dashed lines indicate the 
most clinical operating frequencies. 
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FIG. 4.6 a) longitudinal r1 and b) transverse r2 relaxivities vs. frequency for samples A to D and the 
commercial CA, Endorem. Dashed lines indicate the operating frequencies of most clinical imagers (  
8.5, 21 and 63 MHz). 
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The SPIONs are negative contrast agents and they decrease the signal intensity. The 
most important parameter to determine their contrast efficiency is the transverse 
relaxivity r2. As one can see in Fig 4.6, the transverse relaxivity of the samples is 
increasing with the particle core size and the best efficiency is obtained for the biggest 
particles, i.e. sample D.  
The r1 value gives us the information about the physical phenomena responsible for 
the nuclear relaxation such as diffusion, anisotropy, etc. For our samples, the longitudinal 
relaxivity curves are constant for low frequencies. In the range from 1 to ~10MHz r1() 
shows a maximum for sample A and Endorem that have similar DP (see Table 4.1), which 
is not present for the rest of the samples; apparently in our system there is a threshold in 
the particle size around 8nm over which this maximum is no longer present. The r1() 
rapidly decreases for higher frequencies. The transverse relaxivity has a linear behaviour 
in the studied frequency range with a slope very close to zero.  
Regarding the mechanisms that induce nuclear longitudinal relaxation in SP particles, 
it is worth to remind that the main mechanisms are [5,6]: (i) for <1-5 MHz, the Neel 
relaxation of the particle magnetization, giving a correlation time related to the magnetic 
anisotropy barrier, and an associated reversal time, N, that follows the Arrhenius law; (ii) 
for >1-5 MHz, the Curie relaxation, which takes into account the sample magnetization 
through the squared Langevin function weighted by the spectral density function JF(D), 
where D = 1/D, D being the correlation time related to the diffusion of the water. While 
the mechanism (i) gives a flattening of r1() at frequencies <1-5 MHz, the mechanism 
(ii) is responsible of the maximum in r1() at higher frequencies >1-5 MHz, see 
Endorem and sample A in Fig. 4.6a. In addition, for particles characterized by a distance 
<5nm between the magnetic core and the hydrogen nuclei of the bulk water (eventually 
permeating the coating), “dispersion” at intermediate frequencies occurs [5]. As said 
above, no high-frequency maximum is observed in most of our samples. This fact can be 
tentatively attributed to the dominant role of the magnetic anisotropy that “covers” the 
high frequency feature arising from Curie relaxation, possibly depressed by a scarce 
contribution of  the diffusion process to r1(). This experimental evidence suggests also 
that the bulk water does not penetrate the MNPs coating and so does not diffuse close to 
the magnetic cores.  
A detailed discussion on the frequency dependence of longitudinal relaxivity in our 
system would require further experimental and theoretical investigations that we are 
currently undertaking. Here, we will restrict to an analysis of the variation of 
(1/T1)s=R1() and (1/T2)s=R2() at low frequencies for different particle sizes. Roch and 
Muller proposed a theoretical model that relates R1 and R2 to the energy levels of a 
magnetic particle of spin S obtained from a simplified Hamiltonian accounting for 
(magnetic) anisotropy energies [6]. This model is computer-time-consuming and, as such, 
inapplicable to large particles with a high total spin, S. To overcome these limitations, the 
authors suggested an alternative heuristic model where R1 and R2 are expressed (Eqs. 31 
and 32 in Ref. [6]) as the sum of two contributions corresponding to the limits of zero and 
high anisotropy in the complete theory, respectively. The expressions of R1 and R2 can be 
simplified (the Langevin term in particular) for low frequencies, and still reproducing the 
increase of the absolute values of R1 and R2 with particle size in this frequency range, as 
follows: 
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where SP is the magnetic moment of the nanoparticle, H the gyromagnetic ratio of 
protons, NSP the number of particles per litre, R the particle radius, D the diffusion 
coefficient, D the diffusion correlation time of the water molecules, N the Néel 
relaxation time, S and H the electron and proton Larmor angular frequencies, and JF is 
a spectral density function accounting for the proton diffusion in the non uniform 
magnetic field created by SP, and its fluctuation around its mean value; 0 is an 
adjustable parameter that considers the anisotropy field in the electron Larmor angular 
frequency (0 < S), and P and Q (P+Q  1) are weighting factors for functions 
corresponding to zero and high anisotropy cases, respectively. Fig. 4.7 shows that this 
approximation is valid up to 1 MHz. 
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FIG 4.7. Theoretical frequency dependence of longitudinal and transverse relaxivities and their low 
field approximation (lines) divided by Ci using the same parameters as in Fig. 8 of ref. [6]. 
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As the absolute values of the terms in brackets multiplying C1 and C2 in Eq. 1 and 2 
hardly change with the magnetic core diameter DP, in the low frequency range the most 
important contribution to the size dependence of R1 and R2 comes from the term 
SP2NSP/R. It is important to note that the iron concentration, commonly used to 
normalize the NMRD curves of different samples, is implicit in the particle density or 
number of particles per litre (NSP) so that, for a fixed iron concentration, the particle 
density differs among samples with different particle size.  
Fig. 4.8 shows that r1 and r2 absolute values at low frequency increase quite linearly 
with 2 ( / )SP SPN R . Therefore, the main reason for the increase with size of r1 and r2 
along the series of samples is caused by an increment of SP. 
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FIG. 4.8. Low frequency r1 (open symbols) and r2 (full symbols) absolute values as a function of 
2 ( / )SP SPN R  for samples A to D. SP and NSP are extracted from the fit of  vs. H in Fig. 4.5. 
 
 
  
 
On the other hand, for the contrast enhancement of magnetic spheres, different 
regimes are predicted [8,9]. The first one, which is called “motional averaging regime” 
(MAR) or “motional narrowing regime” describes the transverse relaxation for relatively 
small particles that are homogeneously dispersed in solution. This theory implies that 
water diffusion between particles occurs on a much faster time scale than the resonance 
frequency shift (and predicts identical values for R2(=1/T2) and R2*(=1/T2*)). In this 
regime, the transverse relaxivity increases with increasing particle size. For larger 
particles, this theory breaks down. In this case, the relaxation rates are given by the 
“static dephasing regime” (SDR) theory. The SDR, first introduced by Yablonskiy and 
Haacke [10], implies that a large magnetic perturber produces strong dipolar fields in its 
surroundings, the result of which is the fact that, in contrast to the MAR, diffusion has a 
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minimal influence on nuclear magnetic resonance signal decay. The SDR places an 
absolute limit in the transverse relaxation rate: increasing the perturber size will not result 
in higher relaxation rates.  
We found that our bio-ferrofluids, which are homogeneously dispersed nanoparticles, 
satisfy MAR theory because transverse relaxivity r2 increases with increasing core size.   
Actually, for a further increase in size of the superparamagnetic core of polymer-
coated particles, the increase in R2 and R2* should be violated at some point due to the 
decreasing influence of diffusion and thus reaching the SDR condition.  
 
4.1.4 In Vitro MRI Experiments 
 
To confirm the relaxivity results, according to the NMRD profiles, samples C and D 
with the highest r2 values at 8.5 MHz (see Fig. 4.6b) were selected for MRI experiments. 
To this aim, an Artoscan S.p.A imager was employed. Prior to imaging, the iron 
concentration of all samples together with the Endorem® was carefully fixed at 0.02 
mg/mL.  
In Fig 4.9 images of three vials containing samples C, D and Endorem®, are presented 
using two different pulse sequences a) high resolution Gradient Echo with 
TR/TE/NEX=1000ms/16ms/4, matrix=256*192, FOV=180*180, flip angle=90o; and b) 
high resolution Spin Echo sequence with TR/TE/NEX=1000ms/26ms/4, 
matrix=192*192, FOV = 180*180. For both sequences we selected five slices with the 
thickness of 5mm. 
It is apparent for both sequences that the signal of sample D is darker than Endorem® 
and therefore shows a better performance to decrease the transverse relaxation time T2 as 
a negative contrast agent at the imager operating frequency, i.e. 8.5MHz. These results 
are consistent with what we found from relaxivity experiments.   
 
4.2 CNCs 
 
4.2.1 Characterizations  
 
TEM of the bare SPIONs, show that uncoated SPIONs have the mean diameter of 5 
nm in the absence of surfactants (Fig 4.10a).  
By increasing the alkalinity of the solution (NaOH molarity from 1 to 4) in the 
presence of PVA, the magnetite nanoparticles spontaneously aggregate to form CNCs, as 
shown in the representative TEM images in Fig 4.10b-e. It is noted that the single coated 
SPIONs were formed in the lowest base molarity (i.e. 1). According to the TEM images, 
these monodisperse PVA coated CNCs are made up of superparamagnetic magnetite 
nanoparticles with the size of 5 nm. The hydrodynamic size of the obtained 
monodispersed CNCs is about 50 nm and increases by simply increasing the molarity of 
NaOH while keeping all other parameters fixed. The same behavior was detected for the 
CNCs which were synthesized by using a high-temperature hydrolysis reaction in the 
presence of polyacrylic acid [11,12]. The average size of synthesized samples, measured 
by X-ray diffraction (XRD), TEM, and DLS, is given in Table 4.2. In order to define the 
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polydispersity of the various coated SPIONs, we calculated the variance over 20 particles 
in the TEM images using the standard formula 
 
 
 
 
 
FIG. 4.9 MRI images of vials containing bio-ferrofluids C, D and Endorem® with the same 
concentrations (0.02 mg/ml) obtained by Artoscan S.p.A imager at 8.5MHz: a) high resolution Gradient 
Echo with TR/TE/NEX=1000ms/16ms/4, matrix=256*192, FOV=180*180, flip angle=90o; and b) high 
resolution Spin Echo sequence with TR/TE/NEX=1000ms/26ms/4, matrix=192*192, FOV = 180*180. 
 
 
 
FIG. 4.10 TEM images of (a) the bare SPIONs, and magnetite CNCs obtained from the solutions with the 
molarity of (b) 1, (c) 2, (d) 3, and (e) 4 in the presence of PVA; (f) TEM image of the crosslinked-PEGF 
coated CNCs prepared from the solution with the molarity of 4. The scale bar is 50nm. 
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TABLE 4.2 Average size of SPIONs and CNCs, measured by X-ray diffraction (XRD), TEM, and 
DLS. 
Sample Remark 
Average Core 
Size of 
SPIONsa(nm) 
Average 
Hydrodynamic 
Sizeb(nm) 
Average 
Hydrodynamic 
Sizec(nm) 
 
Bare SPIONs 
No surfactant 
 in the synthesis 
medium. 
5 5 ±1.1 
(core size) 
--------* 
Synthesis base 
molarity: 1 
5 10.5±1.7 12.5 
Synthesis base 
molarity: 2 
4.5 21±2.3 23 
Synthesis base 
molarity: 3 
5 33±3.1 41.5 
 
PVA- 
Coated CNCs 
Synthesis base 
molarity: 4 
4.5 48±4.9 55.1 
PEGF-Coated 
CNCs 
Polymeric shell: Cross-
linked 
 
5 
 
52±5.6 
 
56.5 
a measured by XRD, b measured by TEM, c measured by DLS, * since bare SPIONs are very eager to 
reduce their surface energy in the absence of surfactants, severe agglomeration may occurred; hence, their 
DLS data is not reliable.  
 
 
 
 
 
 
 
It is well recognized that the saturation magnetization of the CNCs is enhanced by 
increasing their size; hence we employed the CNCs which were synthesized in basic 
molarity of 4, for crosslinkable PEGF coating.  
 
4.2.2 SQUID Magnetometry 
 
It is well known that the magnetic magnetization of SPIONs strongly depends on the 
way how the cooling of the system is done before or during the measurements [13]. 
Typically there are two types of magnetization, zero-field-cooled (ZFC) magnetization 
and field-cooled (FC) magnetization. In the case of the ZFC magnetization, the system is 
cooled in the absence of an external magnetic field (H) from high temperatures well 
above a freezing temperature TB (blocking temperature) to the lowest temperature well 
below TB. After H is applied at the lowest temperature, the ZFC magnetization is 
measured with increasing temperature (T). In contrast, the FC magnetization is measured 
in the presence of H with decreasing T from high temperatures well above TB to the 
lowest temperature well below TB. For SPIONs [14], the ZFC magnetization exhibits a 
peak at the blocking temperature TB, while the FC magnetization monotonically increases 
with decreasing T, showing no anomaly at TB.  
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Sample solutions of CNCs were dried to solid form and the magnetization experiments 
were performed using a dc SQUID (Quantum Design MPMS XL) magnetometer. The 
temperature-dependence magnetization of the CNCs has been greatly different between 
the ZFC and FC measurements, as expected. In a ZFC measurement, the sample was 
cooled from T=300K to T=2K without applying any external magnetic field. Once 
reaching T=2K, a magnetic field of H=10 mTesla was applied and the magnetization of 
the sample was measured while the temperature was increasing. The magnetization 
increased as the temperature raised from 2K (see Fig. 4.11) and started to decrease after 
reaching a maximum corresponding to the blocking temperature. In the FC measurement, 
the sample was cooled to 2K under a 10 mTesla applied magnetic field and the 
magnetization was measured while cooling down. The FC magnetization steadily 
increased as the temperature decreased.  
The ZFC-FC curves and the relevant parameters are shown in Fig 4.11 and Table 4.3, 
respectively. The curves represent the typical behaviour of superparamagnetic 
nanoparticles. The blocking temperatures TB, corresponding to the maximum in the ZFC 
curves, are all placed in the temperature range 145-180K. Below TB, the spins freeze and 
the system enters the blocked regime with typical out-of-equilibrium behaviour [15-17].  
The difference in the blocking temperature for different samples is related to the 
different coatings. When the inter-particle separation increases, the magnetic dipole–
dipole interaction reduces and the blocking temperature decreases. This result is typical 
for coated nanoparticles where the coating reduces the magnetic interaction. Kim et al. 
[18] showed similar effects for iron oxide particles covered with an oleate layer and 
Tartaj et al. [19] showed similar effects for 2 3Fe O   particles dispersed in silica. 
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FIG. 4.11 ZFC and FC magnetization measurements of dry powder of the CNCs using a dc SQUID 
magnetometer. The applied magnetic field is H=10mTesla and the data are reported per gram of magnetite.  
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TABLE 4.3 Magnetic parameters extracted from ZFC/FC curves and hysteresis loops. 
Sample Bare  SPIONs 
PVA-Coated 
CNCs 
PEGF-Coated 
CNCs 
Crosslinked-
Coated CNCs 
( )BT K  148.54 166.54 161.26 178.34 
( )cH mT  53.8 56.1 53.0 54.9 
3 4
( / )r Fe OM emu g  5.31 7.16 16.27 14.73 
 
 
 
 
 
We have not observed a sharp blocking transition (as expected for a monodisperse 
system with a very tight size) but rather have a broad transition which is realized in 
polydisperse nanoparticles with a broader size distribution. In other words, the broad 
maximum may indicate that the agglomeration is inhomogeneous and the different 
aggregates are becoming blocked at varied temperatures, creating the distribution of 
blocking temperatures. It is also notable that there is a difference in magnitudes for the 
CNCs with different coatings. The PEGF- and crosslinked PRGF- coated CNCs have 
greater magnetization which might be explained by their coating effect which improves 
the spin-ordering at the surface. That is, bare SPIONs and PVA-coated CNCs have a high 
degree of spin-disorder. 
To further characterize particle behavior and to confirm that the particles were in fact 
superparamagnetic, hysteresis curves were analyzed. Magnetic domains of ferromagnetic 
materials have a magnetic memory where once aligned in an applied field, they do not 
return to their original state without energy expense. This dependency on recent history 
traces a hysteresis loop and energy loss is measured by the area of the loop. 
Superparamagnetic materials at high temperature have no permanent magnetic 
moment and, hence, no hysteresis. Instead at low temperature, where the spins are frozen, 
when it is possible to individuate an axis of anisotropy and to measure M along such axis 
on a single crystal, opening of the hysteresis can be observed. The degree of opening 
depends on sample's properties and, in powders, average over different directions. To test 
the magnetic behavior of the CNCs, the temperature was held constant at T=2K and 
300K for hysteresis measurements in the applied field ranges ±5Tesla (Fig. 4.12). The 
low temperature hysteresis (Fig 4.12a) are slightly open with small coercive fields in the 
range 53 57cmT H mT   and a small remanent magnetization, 
3 4 3 4
5 / 17 /Fe O r Fe Oemu g M emu g  , while the high temperature hysteresis curves (Fig 
4.12b) are not open, as expected for SPIONs and superparamagnetic CNCs [20-26]. The 
extracted data are given in Table 4.3. 
 
4.2.3 NMR Relaxometry 
 
As mentioned before, the efficiency of an MRI CA is determined by measuring the 1H 
nuclear longitudinal r1 and transverse r2 relaxivities. The NMRD profiles for all samples 
and for the commercial compound Endorem® are shown in Figs. 4.13a and 4.11b.  
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FIG. 4.12 Magnetization vs. magnetic field at (a) 2K and (b) 300K for all the CNCs; the insets are zooms 
on the curves of PVA-coated CNCs with the same axis units.  
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Fig. 4.13a shows that the longitudinal relaxivity values of the PEGF-coated and the 
PVA-coated CNCs at very low frequencies are comparable with Endorem® while for 
higher frequencies all the samples have lower values. Looking at Figs. 4.13a, one simply 
can see that there is a decrease in the longitudinal relaxivity of CNCs compared to 
Endorem®. This decrease in the relaxivity is related to the agglomeration of the CNCs 
which are made of the ensembles of the SPIONs. 
Particles containing only one ferrite crystal behave different from those having 
relatively larger particles containing several magnetic crystals within the same flake of 
permeable coating. For the former ones, a theoretical approach assuming a uniform 
distribution of the magnetic crystals within the solvent is rather realistic and allows the 
calculation of the nuclear magnetic relaxation rate [27-29]. This assumption is no longer 
valid for the clusters such as our systems, i.e. CNCs, which contain several ferrite crystals 
per particle.  
Generally, the effects arising from the aggregation of magnetic grains can be divided 
in two: on one hand, those related to the global structure of the cluster and to the 
magnetic field distribution around it, and on the other hand, those limited to the inner part 
of the aggregate. While the former ones essentially affect T2 and T2* [28,30], the latter 
ones govern T1. 
The cluster itself may be considered as a large magnetized sphere whose total 
magnetic moment increases according to the Langevin’s law. The global magnetization 
of the agglomerate is always aligned with the external field. Its effect on relaxation is 
characterized by a long correlation time, because of its large size, so that its contribution 
mainly affects the secular term of the relaxation rate. This contribution is given by the 
outer sphere diffusion theory, provided the motional averaging condition is fulfilled 
. 1Da  , where   is the difference in angular frequency between the local field 
experienced by a proton at the cluster surface and in the bulk; Da  is the translational 
diffusion time around the cluster ( 2 /Da aR D  , Ra being the cluster radius and D the 
water diffusion coefficient) [31]. 
It has been shown [32] that accounting for agglomeration is mandatory for explaining 
the relaxation properties of superparamagnetic colloids and the published models [27-29] 
do not incorporate such a feature: they only apply to non-agglomerated suspensions, 
where each flake does not generally contain more than one ferrite crystal. Agglomeration 
modifies relaxivities. 
Longitudinal relaxation undergoes quite different modifications under agglomeration: 
NMRD profiles become flatter, because of an important decrease of the relaxation rates. 
This effect is interpreted as the result of a virtual exchange between the water inside the 
agglomerates, rapidly relaxed, and the waters within the bulk, relaxing much slower. In 
such cases, the time spent by the water molecules within the agglomerate is not simply 
given by the usual diffusion time 2 /Da aR D  , it is instead deduced from the exact 
solution of the diffusion equation in a finite spherical space, producing an ensemble of 
decaying modes each characterized by its own decay time. These modes play the same 
role as binding sites with a short relaxation time, and with a residence time corresponding 
to the decay time of the diffusion modes. 
Fig. 4.13b shows that the transverse relaxivities of all the samples are approximately 
constant in the frequency range of study. The transverse relaxivities of PEGF-coated, 
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PVA-coated, and crosslinked PEGF-coated CNCs are almost comparable to Endorem®. 
As the r2 value is the crucial parameter for a negative contrast agent (the higher r2, the 
better the MRI contrast), the CNCs can be in principle usefully employed in MRI. 
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FIG. 4.13 (a) Longitudinal r1 and (b) transverse r2 relaxivities vs. Larmor frequency for all CNCs together 
with the commercial CA, Endorem.  
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4.2.4 In Vitro MRI Experiments 
 
In order to investigate the efficiency of CNCs at the level of in vitro MRI, we 
collected images at ~8.5MHz. To do that, five vials containing 4 of our samples and 
Endorem® have been prepared with the same concentration c=0.02 mg/mL and placed in 
the MRI Imager. The obtained image, using a Spin Echo T2 pulse sequence and 
TR/TE/NEX=2000ms/80ms/1, matrix=256*192, and FOV=180*180 as imaging 
parameters, is shown in Fig. 4.14. As one can see, PEGF-coated, PVA-coated, and 
crosslinked PEGF-coated CNCs show a contrast nicely comparable with Endorem®. Fig. 
4.14 shows that the signal intensity is the lowest (i.e. the maximum efficiency) for PEGF-
coated particles and increases going to PVA-coated, crosslinked PEGF-coated CNCs and 
bare SPIONs. As we know that the higher r2 the lower the signal, these results are fully 
consistent with the relaxometry data (see Fig. 4.13b). 
 
 
 
 
 
FIG. 4.14 MRI image of vials containing different CNC samples with the same iron concentrations (0.02 
mg/ml) obtained by Artoscan S.p.A. imager at H=0.2T. (1) Endorem, (2) bare SPIONs, (3) PVA-Coated 
CNCs, (4) PEGF-coated CNCs, (5) Crosslinked PEGF-Coated CNCs. Image parameters: 
TR/TE/NEX=2000ms/80ms/1, matrix=256*192, and FOV=180*180. 
 
 
 
 
 
4.2.5 Cell Endocytosis and Drug Release 
 
The biocompatibility of PVA- and PEGF- coated SPIONs using the 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, has been already 
confirmed [33,34]. 
Here, TEM has been employed to investigate the possibility of entrance of the coated 
CNCs inside the L929 cells through a mechanism of uptaking induced by their 
hydrophilic and biocompatible coatings; the uptake of these CNCs are essential for the 
cellular drug delivery and imaging purposes. As shown in Figs 4.15b and 4.14c, both the 
PVA-coated and crosslinked PEGF-coated CNCs are accumulated within the cells. This 
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is likely due to the electrostatic interactions between the negatively charged membranes 
and the positively charged surface-saturated PVA-coated CNCs and crosslinked PEGF-
coated CNCs (9.5 and 11 mV, respectively), resulting in the uptake of the CNCs by the 
cells. The TEM observations show that the CNCs were present in the membrane-bound 
multivesicle bodies, having entered the cells as larger aggregates. Little organelle damage 
following exposure to both the PVA-coated and crosslinked PEGF-coated CNCs, is also 
evident. The levels of damage in the cells, exposed to the coated CNCs, were negligible, 
confirming the biocompatibility of magnetic CNCs. The nuclei and organelles in the 
control cells remained intact. 
On the other hand, the CNCs, once accumulated inside the desired tissue/cells as a 
drug delivery system, should be able to release their drug payload at an optimal rate. 
However, it is observed that the majority of the drug payload is quickly released upon 
injection into the in vivo environment (the so-called burst effect), since the drug is loaded 
on the surface of CNCs. Consequently, very small (inadequate) amount of the drug reach 
the specific site after e.g., proper antigene-antibody targeting. 
 
 
 
 
 
 
FIG. 4.15 (a) TEM image of the control L929 cells. (b) TEM image of the L929 cells exposed to the PVA-
coated CNCs. (c) TEM image of the L929 cells exposed to the cross-linked PEGF-coated CNCs. 
 
 
 
 
Fig. 4.16 illustrates drug release from PEGF- and crosslinked PEGF- coated single 
nanoparticles and PVA-,  PEGF- and crosslinked PEGF- coated CNCs over 12 days. 
According to the results, the crosslinking of the PEGF hydrogel caused a significant 
decrease in the burst effect not only for the coated CNCs but also for the single coated 
SPIONs; thus, as predicted, the crosslinked system have a great potential to control the 
burst effect even in this very simple drug loading system. Here, the drug was trapped in 
the crosslinked shell, consequently the barriers, for the reduction of the drug-gradient 
concentration, are gradually increased due to the existence of the crosslinked shell; hence 
its release (due to the lower diffusion process) has been kinetically controlled. More 
specifically, the TMX burst effect of the single PEGF coated SPIONs and PEGF coated 
CNCs reduced from 73% to 52% and from 61% to 41%, respectively. The crosslinked 
PEGF-coated CNCs have the lower burst effect compared to the single coated 
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nanoparticles: the reason is the lower chemical activity of CNCs in comparison to the 
single nanoparticles. Additionally, PVA coated CNCs have a burst effect similar to non-
crosslinked PEGF one. It should be noted that a better control over burst effect could be 
obtained using more sophisticated drug loading methods, like e.g. conjugating the drug to 
the crosslinked PEGF CNCs. 
 
 
 
 
FIG. 4.16 Release profile of (a) TMX and (b) DOX from PEGF- and crosslinked PEGF- coated single 
nanoparticles; and PVA- (obtained by the base molarity of 4), PEGF- and crosslinked PEGF- coated CNCs 
over 300 and 200 hours, respectively. 
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5.1 Conclusions 
 
In this thesis we investigated the magnetic and relaxometric properties of two novel 
classes of superparamagnetic nanoparticles with polymer coatings and capability of being 
functionalized. The effect of core size and the type of coating has been studied. 
Obviously, to use a compound for the biomedical applications, one of the most important 
parameters is its biocompatibility which was a great motivation to study the present 
biocompatible systems. The advantages of investigated samples that motivated our 
research can be summarized as follows:   
 
1) Multifunctional polymer-based nanostructured bio-ferrofluids, in brief bio-
ferrofluids: These bio-ferrofluids represent a class of multifunctional maghemite/polymer 
composites, made of fully biocompatible ingredients. Previously, some very important 
characteristics and properties of these samples have been established, i.e.: 
1. They have not shown any in vivo toxicity: after one month, the mice did not 
show any anomaly and an analysis of the organs, after being sacrificed, did not 
reveal neither any damage nor a significant accumulation of the bio-ferrofluids.  
2. Haematology studies of the samples revealed no problem with the blood. That is, 
no anomalies in morphology and number of erythrocytes, leukocytes and 
platelets and observing normal size curves  for all of them; no aggregation; no 
change in the haemoglobin concentration; and no haemolysis. Moreover, as an 
additional interesting effect, they are anticoagulant. Therefore, besides the bio-
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magnetic applications, these materials could be also useful in other biomedical 
applications where anticoagulant agents are requested. 
3. In cell experiments, low cytotoxicity (opossum kidney cells) has been reported.  
4. Bio-ferrofluids have been also functionalised with an optical dye (fluoresceine 
and rhodamine), attached to the surface, which permits to track the pathway of 
the particles across the cellular membrane and inside the cell. It has been 
observed that the particles are internalized by the cells and they do not enter into 
organelles such as mitochondria, or ribosomes, but they accumulate in 
lysosomes. This allows suggesting them also for optical imaging. 
5. In order to study the efficiency of the samples for the therapeutic applications, 
the hyperthermia efficiency has been investigated. The measurements have been 
performed for several frequencies, in the frequency range 2 kHz to 100 kHz, at 
several intensities of ac magnetic fields. The best performance has been obtained 
for the largest particle size (sample D) which is outstandingly larger than 
Endorem and substantially larger than ChemiCell (pure magnetite dispersed in 
water). 
Since the main idea of these samples is to use them for theranostics, i.e. simultaneous 
diagnosis and therapeutics applications, one had to study also their magnetic and 
relaxometric properties. We studied the efficiency of bio-ferrofluids as MRI contrast 
agent versus particle sizes. Both longitudinal and transverse relaxivities show a strong 
increase with the particle size in relation to the increase of the magnetic moment. The 
best efficiency (i.e. the transverse relaxivity, the main parameter for superparamagnetic 
contrast agents) is reached for the maximum magnetic core diameter d~15nm, sample D. 
This is in accordance with the predictions of the theoretical model by A. Roch and R. N. 
Muller [1]. Remarkably, sample D has demonstrated a MRI efficiency superior to a well-
known commercial product, i.e. Endorem®, both in transverse relaxivity measurements 
and in vitro MRI experiments. From fundamental physics point of view, for the bio-
ferrofluids we found that in the relaxation process the magnetic anisotropy role is 
dominant and the bulk water does not penetrate the MNPs coating and so does not diffuse 
close to the magnetic cores. Moreover, we found that our bio-ferrofluids, which are 
homogeneously dispersed nanoparticles, satisfy MAR theory because transverse 
relaxivity r2 increases with increasing magnetic core size. The presented multifunctional 
bio-ferrofluids have thus proven to be very interesting model systems for both 
fundamental studies of nuclear relaxation induced by superparamagnetic nanoparticles 
and clinical MRI. Particularly, sample D has the best MRI efficiency which couples to its 
very good hyperthermia efficiency and gives a system for therapy and diagnostics 
applications, as it was hoped at the beginning of the research.   
 
2) Superparamagnetic colloidal nano-crystal clusters (CNCs), in brief CNCs:  
CNCs are a class of PVA-, PEGF- and crosslinked PEGF-coated colloidal 
nanocrystals with a magnetic core of magnetite. The following properties of CNCs have 
been previously established: 
1. The biocompatibility of the CNCs has been proved by the 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and all of 
them have demonstrated acceptable levels of cell viability following exposure up 
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to 400mM, with none showing toxic effects at the concentrations tested. The 
PEGF coated samples showed better biocompatiblity than the PVA coated ones. 
2.  In order to investigate if these systems could be useful for the targeted drug 
delivery, the drug release from CNCs has been studied. The study revealed that 
by introducing a crosslinking agent to the system, the burst effect was reduced 
by 21%. Thus the crosslinked magnetic nanoparticles are able to reduce the burst 
effect. 
The aforementioned points are strong evidences for suggesting the CNCs for 
biomedical applications and due to their superparamagnetic properties; it is possible to 
track them in the body using the magnetic field. The magnetic properties and the MRI 
efficiency have been investigated to state if they can be novel candidates for theranostics 
applications. Differently from bio-ferrofluids presented above, the CNCs play their 
theranostic role in releasing a drug, while still the diagnosis is thought to be obtained 
through MRI.     
The efficiency of our systems, to contrast suitably the MR images has been 
demonstrated by the relatively high values (comparable to the commercial compound 
Endorem®) of the transverse relaxivity r2 in the PEGF-coated, crosslinked PEGF-coated 
and PVA-coated CNCs, at frequencies of  clinical applications. The efficiency of the 
compounds has been confirmed by the MRI in vitro experiments. Summarizing, the 
CNCs (and specially the crosslinked ones) are biocompatible, show a relatively 
controlled burst effect (meaning that are good candidates for the targeted drug delivery), 
and behave like good negative MRI contrast agents. Therefore, this novel class of 
magnetic nanoparticles could be introduced for the theranostics (MRI + drug release) 
applications.  
From fundamental physics point of view, Fig. as 4.13a shows, the longitudinal 
relaxivity values of the PEGF-coated and the PVA-coated CNCs at very low frequencies 
are comparable with Endorem® while for higher frequencies all the samples have lower 
values. Looking at Figs. 4.13a, one simply can see that there is a decrease in the 
longitudinal relaxivity of CNCs compared to Endorem®. This decrease in the relaxivity is 
related to the agglomeration of the CNCs which are made of the ensembles of the 
SPIONs. Particles containing only one ferrite crystal behave different from those having 
relatively larger particles containing several magnetic crystals within the same flake of 
permeable coating. For the former ones, a theoretical approach assuming a uniform 
distribution of the magnetic crystals within the solvent is rather realistic and allows the 
calculation of the nuclear magnetic relaxation rate [2-4]. This assumption is no longer 
valid for the clusters such as our systems, i.e. CNCs, which contain several ferrite crystals 
per particle.  
Generally, the effects arising from the aggregation of magnetic grains can be divided 
in two: on one hand, those related to the global structure of the cluster and to the 
magnetic field distribution around it, and on the other hand, those limited to the inner part 
of the aggregate. While the former ones essentially affect T2 and T2* [3,5], the latter ones 
govern T1. 
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5.2 Future Directions 
 
We studied two different superparamagnetic systems for biomedical applications. 
The bio-ferrofluids with the largest core size have been demonstrated to be very 
good for both hyperthermia and MRI. Since their cytotoxicity has been also proved to 
be small, in next future it is planned to test them in vivo and possibly study their 
efficiency in clinical diagnosis and therapy. First, we will perform MRI in vivo 
experiments, looking at the contrast and the nanoparticles uptaking by the normal 
cancerous tissues. Secondly, we’ll perform in vivo hyperthermia experiments trying to 
reduce the tumor growth/size with applying a magnetic field for a certain time 
interval and of proper strength and frequency. The MRI will allow us to follow the 
tumor evolution before and after the magnetic hyperthermia treatment.     
The results for the CNCs are also very promising for theranostics applications. So 
far, it has been shown that the drug release in the crosslinked compounds is very 
effective and they are good candidates as negative MRI contrast agent. Therefore, 
both diagnostics and therapeutics are possible. It has been planned to look for a 
specific tumor sensitive to the doxorubicin and to inject a physiological solution of 
drug-loaded CNCs with well established concentration in an in vivo model of tumor. 
The tumor is expected to regress upon the action of the drug and its regression will be 
followed with time by MRI experiments. 
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A.1 Magnetic Field Gradients 
 
To produce an image of a specific tissue placed at a certain point, the presence of a 
gradient field, varying linearly across the sample, is an important issue. Therefore one 
will be able to encode the signal of the spins in space. Fig. A.1 shows how the gradient 
coils are positioned to produce the gradient fields. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIG. A.1 MRI scanner gradient coils. 
 
 
 
 
Two-dimensional (2D) Fourier Imaging is one of the most common imaging 
techniques; that uses three perpendicular pulsed gradients in order to obtain the spatially 
magnetic resonance information. These three gradient fields, so called slice selection, 
phase encoding and frequency encoding, play very important roles and will be explained 
below. 
1. Slice Selection. Slice selection (or selective excitation) is performed by applying a 
magnetic field gradient during the rf excitation. Often, the direction of the slice selective 
gradient is chosen along z (the direction of the applied magnetic field, B0) so, for the sake 
of simplicity, here we will consider only this case, referring to the slice selection gradient 
as Gz, where: 
                                                            0z
BG
z
                                                           A.1 
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It should be noted that only the magnitude of the applied field is affected by the 
gradients and the direction of B0 remains constant all over the sample. 
In presence of Gz, the Larmor frequency becomes a function of z, that is: 
 
                                                 0( ) ( )zz B G z                                                     A.2 
 
By exciting the sample with an rf pulse of rf , only the spins located at 
0( ) / ( )rf zz B G      will be placed into the xy-plane, contributing to the final signal, 
thus selecting a plane of the sample perpendicular to B. For a rectangular rf pulse of 
duration  , there will be a spread of frequencies described by the Fourier Transform 
(FT) of a rectangular window function, i.e., a sinc function centered on rf , with a 
bandwidth proportional to 1/ . The width of the selected slice can be written: 
 
                                                         1
z
z
G                                                            A.3 
 
The main parameter to control the slice thickness is the rf pulse duration. A slice 
profile that is a sinc function however is not ideal, as it produces substantial excitation in 
the lobes away from the selected slice. Improved slice profiles can be obtained by using 
excitation pulses of different shapes such as Gaussian. 
 
2. Frequency and Phase Encoding. Once the slice volume is selected, to determine an 
exact and precise tissue, we will need to apply another two gradients to have each single 
magnetic moment at a certain place and with a certain frequency and phase. Usually, a 
magnetic field gradient is applied along x-direction, Gx, which is switched on during the 
signal acquisition. Therefore the Larmor frequency of each spin will be a function of x, so 
called frequency encoding: 
                                                0( ) ( )xx B G x                                                      A.4 
 
and the slice is cut into strips of constant Larmor frequency. Ignoring the T2 decay, an 
area dxdy in the selected slice gives a contribution dS(t) to the total signal: 
 
                                        0( )( ) ( , ) xi B G x tdS t x y e dxdy                                             A.5 
 
where   is the proton density function and the time origin is set at the Gx activation 
(i.e., at the beginning of the signal acquisition). 
Demodulating the signal, to remove the carrier frequency B0, and integrating over the 
slice, one obtains the following expression for the total receiving signal: 
 
                                            ( ) ( , ) xi G xt
y projectionof
S t x y dy e dx

 

                                             A.6 
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where we recognize the   projection along the y-axis. The   projection along  y can 
be resolved applying, for a certain amount of time, a gradient along y, immediately 
following the selective excitation and just before signal acquisition. By briefly turning on 
the Gy field gradient, the precessional phases of the rotating macroscopic magnetization 
can be manipulated as follows. Gy induces a variation of the Larmor frequency along the 
y-direction, according to: 
                                                  0( ) ( )yy B G y                                                   A.7 
 
If Gy is now turned off after a time y , M returns to the constant frequency 0 , but 
having accumulated a phase shift,  , as a function of y (phase encoding), i.e.,  
 
                                                      ( ) y yy G y                                                        A.8 
 
If now we turn on the frequency encoding gradient and acquire the signal, then the 
FID will be a function of t and y  i.e., 
 
                                  
 ( )( , ) ( , )
( , )
x
x y y
i G xt y
y
i G xt G y
S t x y e dxdy
x y e dxdy
 
 
 

 
   



                                      A.9 
 
Using Gx and Gy we have indexed each nutated macroscopic magnetic moment in the 
selected slice, that is, each (x,y) position, with an unique combination of Larmor 
frequency and Larmor phase, ( ,  ). 
 
A.2 k-Space and Pulse Sequences 
 
Eq. A.9 can be conveniently rewritten as: 
 
                                        ( )( , ) ( , ) x yi k x k yx yS k k x y e dxdy                                     A.10 
Where; 
                                                           x xk G t                                                        A.11 
                                                           y yk G t                                                        A.12 
 
The plane defined by the ( , )k x yk k  points is called k-space, and plays an important 
role in the interpretation of MRI experiments. 
In Eq. A.10 we can note that ( , )x yS k k  and ( , )x y  are FT-pairs. The proton density 
over the slice (i.e., the image, in absence of relaxations) can thus be obtained by taking 
the inverse 2D FT of the demodulated FID over the k-space. ky is varied by stepping 
through different values of Gy, whereas kx is sampled by holding on the frequency 
encoding gradient while sampling the signal discretely. 
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The acquisition of each line of the k-space (i.e.,  ( , ) :x y yk k k const  ) implies at 
least an rf pulse (the excitation), a series of gradient pulses, and the signal acquisition. 
The time course between two subsequent excitation rf pulses is called repetition time 
(TR). The complex sequence of time delays, gradients and rf pulses is known as pulse 
sequence. The total acquisition time of a slice, Tacq is thus given by: 
 
                                                            ( )acq yT N TR                                                A.13 
 
where Ny is the number of ky steps. 
From the properties of the FT, we know that the signal acquired at each k-space 
location contains information about the whole image, but the type of information varies 
across the k-space. Most of the contrast of the final image is encoded at the center of the 
k-space (small kx and ky), while its peripheral part accounts mainly for the high frequency 
contributes to the image, that is, resolution of details and noise. 
The trajectory of the vector k during the pulse sequence can be written as: 
 
                                                    
0
( ) ( )k G
t
t t dt                                                    A.14 
 
where the time origin is now at the beginning of the sequence and G(t) is the general 
function describing orientation, shape and duration of the magnetic field gradients 
applied during the MRI experiment. The k(t) formalism is of great help in interpreting 
complex pulse sequences. 
 
A.3 Steady State and T1-Weighted Images 
 
It should be noted that after each acquisition one should wait (TR), at least five times 
T1, in order to let the longitudinal magnetization recovers completely. Therefore the 
maximum signal will be obtained. This is actually impractical for in-vivo imaging, due to 
the resulting too long acquisition time (see Eq. A.13). In fact, TR is always set T1. 
After a few pulses, the recovered value of Mz reaches a steady state, depending upon the 
T1 of the sample, but always lower than M0. 
The longitudinal magnetization after the n-th TR interval is given by: 
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(1 )
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z z z
n
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
   
                          A.15 
 
where   is the FA of the excitation pulse , and we define: 
 
                                                          1/TR TE e                                                         A.16 
                                                       cosK E                                                         A.17 
 
Writing Eq. A.15 as a sequence we have: 
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and, since 1K  , for n  , the steady state value is: 
 
                                                0(1 )
1
n steady
z z
E MM M
K
                                        A.19 
 
A short TR, together with reducing Tacq, can thus be used to induce a contrast between 
two regions of the sample having the same proton density, but different T1 (T1-weighted 
image). 
 
A.4 Multi-Slice 2D Imaging 
 
The coverage of a 3D volume is accomplished through the multi-slice approach, by 
applying a sequence of rf pulses, exciting different slices, within a single TR. During 
each TR, one k-space line is acquired for all the slices, thus keeping the same Tacq of the 
single-slice acquisition. On the other hand, TR has to be set long enough to allow for the 
pulse sequence of each slice being executed. 
Because of imperfect rf profiles, the immediate neighborhood of an excited slice is 
also partly excited (slice cross-talk effect). In multi-slice imaging, this region cannot be 
included in the following slice since the spins do not have time to recover toward 
equilibrium. To overcome the problem, it is common either to leave a gap between slices 
or to excite the odd number of slices first and the even numbered ones afterwards 
(interleaved acquisition). 
 
A.5 3D Volume Imaging 
 
As an alternative to the 2D multi-slice approach for imaging 3D volumes, the 2D 
coverage of k-space can be generalized to 3D. 
The excitation pulse is used to select a thick slab of the sample, and then the 3D k-
space is discretely sampled in both ky and kz directions, through phase encoding. The read 
sampling along the x-direction is carried out, as in 2D, with measurements at finite time 
steps t  during the continuous application of a gradient Gx. The associated step in the kx 
direction is: 
                                                     x xk G t                                                          A.20 
 
The (kx,kz) position of each acquisition line is determined by applying the orthogonal 
gradients Gy and Gz, for the y  and z  time intervals, respectively. The corresponding 
steps in k-space are: 
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                                                       y y yk G                                                       A.21 
                                                       z z zk G                                                        A.22 
 
where yG  is the difference in Gy intensity between two consecutive read lines, and 
analogously for zG . 
Under 3D imaging conditions, the signal from a single rf excitation of the whole 
sample can be written as a 3D FT of the proton density: 
 
                                                 .( ) ( ) k rk r riS e d                                                  A.23 
 
3D imaging has several advantages compared to the multi-slice imaging: 
1. The ability to change the number of the Nz phase encoding steps over the 
excited slab, of thickness TH, gives the control over the size of the partition 
thickness / zz TH N   without any limitation on the rf amplitude or duration. In 
general, higher z resolutions are obtainable. 
2. The Signal-to-Noise Ratio (SNR) can be enhanced, thanks to the higher 
flexibility in setting the pulse program parameters available in 3D imaging, but 
achieving this may come at the expense of increased imaging time. 
3. Consecutive slices may be adjacent without cross-talk effects. 
4. Shorter TR is usable if necessary, since only one k-space line has to be 
acquired for each repetition. 
On the other hand, the total acquisition time for 3D imaging is given by: 
 
                                                       acq y zT N N TR                                                   A.24 
  
where Ny and Nz denote the number of phase encoding steps along y and z. One can 
simply realize from Eqs. A.13 and A.24 that 3D imaging takes more time compared to 
the 2D imaging. 
An immediate consequence is the capability of acquiring more 2D than 3D images 
within the same time, thus allowing a higher temporal resolution, in dynamic studies. 
A more indirect effect is due to the capability (but also the necessity) of setting longer 
TR, given a certain Tacq, in multi-slice imaging. A longer TR implies a higher steady-state 
value of the longitudinal magnetization, thus giving a higher SNR. 
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We have investigated the MRI contrast efficiency of novel maghemite/polymer 
composite ferrofluids that contain anchoring groups for biofunctionalization, can 
incorporate fluorescent dyes and have shown low cellular toxicity in previous studies. We 
have determined that the magnetic core size for reaching the best MRI contrast efficiency 
is d~15 nm. Our experimental results allow us to propose first a set of optimal 
microstructural parameters for multifunctional superparamagnetic ferrofluids to be used 
in MRI medical diagnosis. 
 
 
 
1. Introduction 
 
The use of magnetic nanoparticles (MNPs) may lead to exciting new developments in 
biomedicine.[1-3] Attaching MNPs to a biological entity (e.g., cell, protein, enzyme, 
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antibody, drug, DNA, etc.) permits to perform a variety of operations (i.e., moving, 
fixing, counting, heating, locating, etc.) with minimal interaction, thus leading to a large 
number of applications.[4] For biomedical uses in general, physical performances are 
always subordinated to biocompatibility. Materials that have shown excellent magnetic 
properties can find severe validation difficulties for clinical applications. Another 
desirable feature is multifunctionality. The nanoparticles will be far more useful when 
they are provided with anchoring sites for biological vectors, luminescent labels, drugs, 
etc.[5] The ferrofluids used here have been designed ad hoc for biomedical applications 
taking into account these requisites in the following way:[6-8] a) the magnetic core is 
maghemite, one of the most biocompatible magnetic compounds,[9] the coating is made of 
biocompatible polymers, polyvinylpyridine (PVP) and polyethylenglycol (PEG), and the 
dispersing media is a phosphate buffer saline solution (PBS) with pH=7.4; b) they 
incorporate anchoring groups (-COOH) for biological vectors and luminescent dyes for 
live cell studies; (c) they have shown low toxicity in cells cultures, human blood, and in 
vivo experiments;[8] and (d) they are stable for years.[8] 
A good applicative example of the use of MNPs is magnetic resonance imaging (MRI), 
which is one of the best non-invasive diagnostic techniques in medicine.[10] Despite the 
relatively high number of degrees of freedom for obtaining good MR images of the soft 
tissues of living beings, in some cases it is not possible to have enough image contrast to 
show the tissue anatomy or pathology of interest. In such cases, one has to use contrast 
agent (CA), generally based on paramagnetic or superparamagnetic substances. The CAs 
used in MRI are selected to induce a shortening of the spin-lattice T1 and/or spin-spin T2 
relaxation times of the hydrogen nuclei within the tissues/regions where they are 
delivered, thus allowing a much better image contrast. Most commonly a paramagnetic 
CA, usually a gadolinium-based compound, is used.[11,12] Gadolinium-doped tissues and 
fluids appear extremely bright in MR images, and for this reason paramagnetic CAs are 
called positive CA. More recently superparamagnetic (SP) CAs, based on iron oxide 
MNPs,[13,14] have become commercially available. The regions where such agents are 
delivered appear darker and, therefore, they are called negative CA. The big advantage of 
this type of CA is their higher sensitivity that is expected to reach single cell level.[15] 
In order to exploit the full potential of MNPs in MRI, it is necessary to determine the 
structure/performance relations that would lead to the optimal product. In fact, despite the 
great interest in synthesizing novel more efficient CAs, the influence of microstructural 
parameters like the kind of magnetic ion, the kind and thickness of the coating, the 
dimensions of the magnetic core and of the nanoparticle on the MRI efficiency, has been 
scarcely studied.[16] Studies of such kind on ferrites-based CA with different magnetic 
core dimensions and an amphiphilic polymer or micelles coatings have been reported.[17-
20] In particular, an optimum magnetic core diameter, d ≈ 8-12 nm, has been suggested for 
particles having the same coating but with a thickness slightly dependent on the magnetic 
core size. Other authors have shown that the kind and thickness of coating have a marked 
influence on the relaxivity, as deduced from preliminary studies on Mn-ferrites-based 
compounds.[21] 
Here we examine the relation between particle size, magnetic properties and CA 
efficiency in a polymer-based MNP system that, as described above, is biocompatible and 
suitable for in vivo applications, and has low cellular toxicity and a high capacity for 
multifunctionalization. We measured the 1H Nuclear Magnetic Resonance (NMR) 
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longitudinal r1 and transverse r2  nuclear relaxivities, these parameters measuring the 
increase of the nuclear relaxation rates per unit of magnetic center. In some of the 
investigated samples the transverse relaxivity, which is the most significant parameter for 
the efficiency of negative CAs, resulted comparable with or higher than commercial 
contrast agents. In order to confirm the MRI efficiency of our samples, we also 
performed some MRI in vitro experiments at =8.5 MHz using a low-field Imager.  
This work has been carried out in parallel with similar studies about magnetic 
hyperthermia performances and toxicology. Thus, this is a first part of a general study 
aiming to develop a MNP system optimised for simultaneous diagnosis and therapy 
applications, the so-called theranostics.[22]  
 
2. Results and Discussion  
 
The characteristics of our ferrofluids are shown in Table 1. TEM images (Figure 1) 
show a uniform distribution of iron oxide nanoparticles encapsulated in a continuous 
polymer film. Most of the particles are rounded with an average size that increases 
regularly from 7.4 nm (sample A) to 15 nm (sample D) in relation to the Fe2O3/PVP and 
Fe(II)/Fe(III) ratios selected in the synthesis (Table 1). ED patterns on these particles are 
consistent with a maghemite crystal structure (central image in Figure 1). A small number 
of particles are elongated. 
Table 1. Characteristics of the ferrofluid samples.  
Sample Fe2O3/ PVPa 
Fe(II)/ 
Fe(III)a 
  DH 
(nm )b PDI
c   DP 
(nm)d 
 SD 
(nm) 
 TB 
(K)e 
A 0.5 0.5 59 0.16 7.4 1.2 40 
B 0.625 0.5 62 0.18 8.6 2.0 45 
C 1 0.5 92 0.15 10.8 2.9 160 
D 1 0.9 93 0.14 15.0 3.7 200 
[a] Molar ratios used in the preparation of the sample; [b] Hydrodynamic diameter; [c] Polydispersity 
index as obtained from DLS; [d] Maghemite particle diameter from TEM images; [e] Blocking temperature 
from AC magnetic susceptibility measurements at 30 Hz. 
 
Histograms of the hydrodynamic sizes for the series of samples are shown in Figure 2. 
In all cases a monomodal distribution of particle diameters was found. The average 
hydrodynamic diameter DH increases with the iron oxide/polymer ratio (Table 1) from 59 
nm (sample A) to 92 nm (sample C), and it is hardly changing in samples with similar 
Fe2O3/PVP ratio but different particle size (samples C and D). 
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Figure 1. TEM images of samples A(a), B(b), C (c) and D (d) and a characteristic ED diffraction pattern of 
the particles. In sample D some of the crystals are faceted.  
 
The average sizes of MNPs found by TEM represent about 10-15% of the average 
hydrodynamic sizes. Considering that at the pH of the medium (7.40) pyridine groups are 
hydrophobic and PEG residues are hydrophilic, then the structure of the 
MNP@PVP@PEG beads in suspension could be as follows: an inner part formed by a 
single folded PVP chain entrapping the MNPs by N-Fe coordination bonds, and an outer 
part formed by solvated PEG chains in a radial disposition.  
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Figure 2. Histograms of the hydrodynamic sizes for the series of samples. Colour online. 
 
The AC magnetic susceptibility as a function of temperature of samples A to D shows 
the characteristic behaviour of the superparamagnetic systems, with the in- and out-of-
phase components (’ and ’’, respectively) depending on frequency and with ’’ having 
a maximum at blocking temperature (TB), which depends on the frequency of the applied 
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field following an Arrhenius like function.[23,24] This shows that at low temperatures the 
magnetic moment of the magnetic nanoparticles can not be reversed, i. e. it is not able to 
cross the anisotropy energy E=KVP (K is the anisotropy constant characteristic of the 
material and VP is the volume of the magnetic nanoparticles) and follow the field. As 
temperature increases, the moments of the nanoparticles with lowest anisotropy energy 
start to reverse, being this process thermally activated and termed Néel relaxation. As 
expected from this model, at a given frequency, TB increases with DP (Figure 3). 
Below 273 K these water based ferrofluids are frozen and thermal activation is the only 
mechanism available for reversal. At room temperature, the nanoparticles whose E is too 
high for the thermal activation to be effective (say E>kBT ) have the possibility to reverse 
by mechanical rotation in the fluid (Brownian relaxation mechanism). The on-set of this 
mechanism leads to a sudden increase of ’’ in the samples with a relevant fraction of 
“large” nanoparticles (i. e. nanoparticles with E> kBT). 
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Figure 3. ’’ vs. temperature for samples A to D. The TB increases with increasing average sizes. Colour 
online. 
From the plot of magnetization versus applied field (Figure 4) it is evident that the 
magnetization increases with increasing particle size as previously found in 
maghemite/PVP composites.[25] Fitting these curves to a Langevin function[26] modified 
by adding a linear term, it is possible to conclude that the average magnetic moment of 
the particles increases with the MNPs size. This model assumes that the core of the 
MNPs behaves as a single spin (with the same value for all MNPs), and that the magnetic 
moments, at the MNPs surface, have a linear behaviour with the field in the studied field 
range.[25] The linear term also accounts for the diamagnetic contributions of the polymer 
coating and the fluid. 
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Figure 4. Magnetization per gram of iron oxide for the series of samples. Lines correspond to fitting to a 
modified Langevin function. Colour online. 
To evaluate the MRI contrast efficiency of the samples, the nuclear longitudinal and 
transverse relaxivities (r1 and r2, respectively) were obtained from the spin-lattice T1 and 
the spin-spin T2 relaxation times measured at room temperature for each frequency, 
as:[10,16]      cTTr disii 11   
Where i = 1, 2, and c is the iron concentration in the sample (in mM), (1/Ti) are the 
nuclear relaxation rates and the suffixes s and d stand for sample and dispersant (in our 
samples PBS at physiological pH), respectively. 
The NMR-dispersion profiles for samples A to D and the commercial compound 
Endorem are shown in Figure 5. The longitudinal relaxivity curves are constant for low 
frequencies. In the range from 1 to ~10 MHz r1() shows a maximum for sample A and 
Endorem, with similar DP (see Table 1), which is not present for the rest of the samples; 
apparently in our system there is a threshold in the particle size around 8 nm over which 
this maximum is no longer present. r1() rapidly decreases for higher frequencies. The 
transverse relaxivity has a linear behaviour in the studied frequency range with a slope 
very close to zero.   
 
0,01 0,1 1 10 100
0,1
1
10
100
r 1
 ( 
m
M
-1 Fe
 s-
1  )
 (MHz)
a)
 A
 B
 C
 D
 Endorem
 
10 100
10
100
303
r 2
 ( 
m
M
-1 Fe
 s-
1  )
(MHz)
b)
 D
 Endorem
 A
 B
 C
Figure 5. a) longitudinal r1 and b) transverse r2 relaxivities vs. frequency for samples A to D and the 
commercial CA, Endorem. Dashed lines indicate the operating frequencies of most clinical imagers (  
8.5, 21 and 63MHz). Colour online. 
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Regarding the mechanisms that induce nuclear longitudinal relaxation in SP particles, it 
is worth to remind that the main mechanisms are:[16,27] (a) for <15 MHz, the Neel 
relaxation of the particle magnetization, giving a correlation time related to the magnetic 
anisotropy barrier, and an associated reversal time, N, that follows the Arrhenius law; (b) 
for >15 MHz, the Curie relaxation, which takes into account the sample magnetization 
through the (square of) Langevin function weighted by the spectral density function 
JF(D), where D = 1/D, D being the correlation time related to the diffusion of the 
water. While the mechanism (a) gives a flattening of r1() at frequencies <15 MHz, the 
mechanism (b) is responsible of the maximum in r1() at higher frequencies >15 MHz, 
see Endorem and sample B in Figure 5a. In addition, for particles characterized by a 
distance < 5 nm between the magnetic core and the hydrogen nuclei of the bulk water 
(eventually permeating the coating), a “dispersion” at intermediate frequencies 
occurs.[16,27] As said above, no high-frequency maximum is observed in most of our 
samples. This fact can be tentatively attributed to the dominant role of the contributiuon 
coming from the magnetic anisotropy that “covers” the high frequency feature arising 
from Curie relaxation, possibly depressed also by a scarce contribution of  the diffusion 
process to r1().  
A detailed discussion on the frequency dependence of longitudinal relaxivity in our 
system would require further experimental and theoretical investigations that we are 
currently undertaking. Here, we will restrict to an analysis of the variation of 
(1/T1)s=R1() and (1/T2)s=R2() at low frequencies for different particle sizes. Roch and 
Muller proposed a theoretical model that relates R1 and R2 to the energy levels of a 
magnetic particle of spin S obtained from a simplified Hamiltonian accounting for 
(magnetic) anisotropy energies.[27] This model is computer-time-consuming and, as such, 
inapplicable to large particles with a high total spin, S. To overcome these limitations, the 
authors suggested an alternative heuristic model where R1 and R2 are expressed (Eqs. 31 
and 32 in Ref. [27]) as the sum of two contributions corresponding to the limits of zero 
and high anisotropy in the complete theory, respectively. The expressions of R1 and R2 
can be simplified (the Langevin term in particular) for low frequencies, and still 
reproducing the increase of the absolute values of r1 and r2 with particle size in this 
frequency range, as follows: 
       NDHFNDSF JQPJCR  ,,37,,,731 011                                (1) 
        NDFNDHFNDSF JJPJCR  ,,06,,7,,,1331 022           NDFNDHF JJ  ,,04,,33                                        (2) 
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RD
NC SPSPH 



                                                (3) 
where SP is the magnetic moment of the nanoparticle, H the gyromagnetic ratio of 
protons, NSP the number of particles per litre, R the particle radius, D the diffusion 
coefficient, D the diffusion correlation time of the water molecules, N  the Néel 
relaxation time, S and H the electron and proton Larmor angular frequencies, and JF is 
a spectral density function accounting for the proton diffusion in the non uniform 
magnetic field created by SP, and its fluctuation around its mean value; 0 is an 
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adjustable parameter that considers the anisotropy field in the electron Larmor angular 
frequency (0 < S), and P and Q (P+Q1) are weighing factors for functions 
corresponding to zero and high anisotropy cases, respectively. Figure 6 shows that this 
approximation is valid up to 1 MHz. 
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Figure 6. Theoretical frequency dependence of longitudinal and transverse relaxivities and their low field 
approximation (lines) divided by Ci using the same parameters as in Figure 8 of reference no. 25. 
As the absolute values of the terms in brackets multiplying C1 and C2 in Eq. 1 and 2 
hardly change with the magnetic core diameter DP, in the low frequency range the most 
important contribution to the size dependence of R1 and R2 comes from the term 
SP2NSP/R. It is important to note that the iron concentration, commonly used to 
normalize the NMRD curves of different samples, is implicit in the particle density or 
number of particles per litre (NSP) so that, for a fixed iron concentration, the particle 
density differs among samples with different particle size.  
Figure 7 shows that r1 and r2 absolute values at low frequency increase quite linearly 
with 


R
N SP
SP
2 . Therefore, the main reason for the increase with size of r1 and r2 along 
the series of samples is caused by an increment of SP. 
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Figure 7. Low frequency r1 (open symbols) and r2 (full symbols) absolute values as a function of 



R
N SP
SP
2  for samples A to D. SP and NSP are extracted from the fit of  vs. H in Figure 4. Color 
online. 
Samples with the highest r2 values at 8.5 MHz (C and D, Figure 5b) were selected for 
MRI experiments. Prior to imaging, the iron concentration of all samples was carefully 
fixed at 0.02 g/L.  
In Figure 8 images of samples C, D and the commercial CA are presented for two 
different pulse sequences, a) High resolution Gradient Echo and b) High resolution Spin 
Echo. It is apparent for both sequences that sample D signal is darker than Endorem and 
therefore shows a better performance as negative contrast agent at the imager operating 
frequency (8.5 MHz). 
 
 
 
Figure 8. MRI images of vials containing samples C, D and Endorem with the same concentrations (0.02 
mg/ml) obtained by Artoscan (by Esaote SpA) imager at 8.5 MHz: a) High resolution Gradient Echo and b) 
High resolution Spin Echo. 
 
3. Conclusions 
 
In summary, we report on the efficiency as contrast agents for MRI of a series of 
multifunctional maghemite/polymer composite ferrofluids, made of fully biocompatible 
ingredients, with several particle sizes. Both longitudinal and transverse relaxivities show 
a strong increase with the particle size in relation to the increase of magnetic moment, the 
best efficiency (i.e. the highest transverse relaxivity as usual for superparamagnetic CA) 
being reached for the maximum magnetic core diameter. This is in accordance with the 
predictions of the heuristic model by A. Roch and R.N. Muller.[27] Remarkably, the 
sample with the highest particle size, D = 15 nm, has demonstrated a capacity as MRI 
contrast agent superior to a well-known commercial product, i.e. Endorem, both in 
Appendix B: Presentations & Publications 
 
 
143 
transverse relaxation measurements and in vitro MRI experiments. The presented 
multifunctional ferrofluids have thus proven to be very interesting model systems for 
both fundamental studies of nuclear relaxation induced by superparamagnetic 
nanoparticles and clinical MRI. Further investigations about the toxicology and the 
ability of our systems as magnetic fluid hypertermia mediators,[28] which could allow to 
propose them as future theranostic agents, are under way. 
 
 
4. Experimental Section 
 
The synthesis of the ferrofluids was performed in two steps: 1) synthesis of 
maghemite/PVP nanocomposites, and 2) synthesis of ferrofluids (using the 
nanocomposites) in a PBS medium.  
Maghemite/PVP nanocomposites were prepared by in situ precipitation from iron–PVP 
coordination compounds, following the procedure described in Ref. [7]. A film of iron-
polymer precursor was obtained by evaporation of a 50% water:acetone solution 
containing 0.2 g of PVP (Aldrich, 60 kD), and variable amounts of FeBr2 (Aldrich) and 
FeBr3 (Aldrich). The precursor film was treated with 20 mL of 1 M NaOH solution for 1 
h, washed with water and dried in open air to obtain a maghemite nanocomposite. The 
size of the maghemite nanoparticles in the composites was tuned by using different 
Fe(II)/Fe(III) and Fe/N ratios. Composites for samples A-C were prepared using a 
Fe(II)/Fe(III) ratio of 0.5 and Fe/N ratios of 0.5, 0.625 and 1 respectively. Composite for 
sample D was prepared using a ratio of 1 for both Fe(II)/Fe(III) and Fe/N. 
The ferrofluids were prepared according to Ref. [6]. The maghemite/PVP 
nanocomposites were dispersed in an acidic solution at pH  3. The resulting acidic 
ferrofluid was mixed with 0.18 mL of PEG (MW=200 D) acrylate (PEG(200)-A) 
(Monomer&Polymer), and 0.02 g of PEG (MW=1000 D) acrylate (PEG(1000)-A-
COOH) (Monomer&Polymer), and was heated to 70 oC during 24 h. Then, Na2HPO4 was 
added for a 0.01 M final concentration, the pH was adjusted to 7.40 by addition of a 0.2 
M NaOH solution, and the ionic strength was adjusted to 0.15 by addition of NaCl and 
KCl. Finally, the dispersion was filtered through a 0.22 m membrane filter to obtain a 
bioferrofluid. 
The total iron content in the samples was determined by atomic absorption in a plasma 
40 ICP Perkin–Elmer spectrometer. The size of the maghemite nanoparticles was 
determined by transmission electron microscopy (TEM) images in a Philips CM30 
microscope. The samples were prepared by dip coating of carbon coated copper grids in 
the ferrofluid solution. The hydrodynamic size distribution of the dispersed nanoparticles 
in the ferrofluids was determined by Dynamic Light Scattering (DLS) using the Zetasizer 
Nano ZS of Malvern. 
The magnetic properties of these ferrofluids where studied by means of dc 
magnetization as a function of field at room temperature and ac magnetic susceptibility 
measurements as a function of temperature and frequency in a MPMS-XL SQUID 
magnetometer from Quantum Design. 
The MRI contrast efficiency was assessed studying the behaviour of the nuclear 
relaxation rates per iron concentration, expressed in mM. The 1H NMR technique was 
employed to measure the longitudinal and transverse relaxivities in a wide range of 
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frequencies covering most of the clinical imagers (  8.5, 21 and 63 MHz corresponding 
to about 0.2, 0.5 and 1.5 T respectively). For 10k Hz    10 MHz, the NMR data were 
collected with a Smartracer Stelar relaxometer using the Fast-Field-Cycling technique, 
while for  > 10 MHz a Stelar Spinmaster and an Apollo-Tecmag spectrometers have 
been used. Standard radiofrequency excitation sequences CPMG-like and saturation-
recovery were applied to determine T2 and T1 values.  
MRI experiments were performed at 8.5 MHz using an Artoscan Imager by Esaote SpA. 
The employed pulse sequences were: a) High resolution Gradient Echo with TR/TE/NEX 
= 1000ms/16ms/4, matrix = 256*192, FOV = 180*180, flip angle = 90o  and b) High 
resolution Spin Echo sequence with TR/TE/NEX = 1000ms/26ms/4, matrix = 192*192, 
FOV = 180*180. Here TE is the echo time, TR the repetition time and NEX the number 
of averages. 
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